{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T14:17:41Z","timestamp":1785421061761,"version":"3.56.0"},"reference-count":567,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T00:00:00Z","timestamp":1780358400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100014188","name":"MSIT","doi-asserted-by":"crossref","award":["RS-2020-NR049559"],"award-info":[{"award-number":["RS-2020-NR049559"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100014188","name":"MSIT","doi-asserted-by":"crossref","award":["NRF-RS-2024-00350362"],"award-info":[{"award-number":["NRF-RS-2024-00350362"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"crossref"}]},{"award":["RS-2020-NR049559"],"award-info":[{"award-number":["RS-2020-NR049559"]}],"id":[{"id":"https:\/\/ror.org\/01wpjm123","id-type":"ROR","asserted-by":"publisher"}]},{"award":["NRF-RS-2024-00350362"],"award-info":[{"award-number":["NRF-RS-2024-00350362"]}],"id":[{"id":"https:\/\/ror.org\/01wpjm123","id-type":"ROR","asserted-by":"publisher"}]},{"name":"Ministry of Education","award":["RS-2020-NR054734"],"award-info":[{"award-number":["RS-2020-NR054734"]}]},{"award":["RS-2020-NR054734"],"award-info":[{"award-number":["RS-2020-NR054734"]}],"id":[{"id":"https:\/\/ror.org\/01p262204","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nutrients"],"abstract":"<jats:p>Cognitive disorders, including Alzheimer\u2019s disease, Parkinson\u2019s disease, schizophrenia, depression, and vascular dementia, are associated with dysregulation of neurotransmitter systems, including acetylcholine, dopamine, serotonin, glutamate, and \u03b3-aminobutyric acid (GABA). These disorders are increasingly recognized as multifactorial conditions involving oxidative stress, neuroinflammation, mitochondrial dysfunction, synaptic impairment, blood\u2013brain barrier disruption, metabolic imbalance, and gut\u2013brain axis dysregulation. Current pharmacological therapies may provide symptomatic relief; however, their clinical benefits are often limited and associated with adverse effects. Herbal medicines have gained increasing attention as potential complementary approaches for cognitive support and neuroprotection. Preclinical evidence and emerging clinical studies suggest that herbal bioactive compounds may exert neuroprotective effects through antioxidants, anti-inflammatory, and neurotransmitter-modulating mechanisms. Medicinal herbs such as Bacopa monnieri, Withania somnifera, Ginkgo biloba, Glycyrrhiza glabra, Moringa oleifera, and ginseng have shown potential cognitive benefits in experimental models and selected human studies. Advanced delivery systems, including nanoparticles and phytosomes, may further improve the bioavailability and brain-targeting efficiency of herbal compounds. However, current clinical evidence remains heterogeneous and limited by insufficient standardization, small sample sizes, and short study durations. Further large-scale clinical studies and standardized safety assessments are essential before herbal neurotherapeutics can be widely applied in cognitive and neurological disorders.<\/jats:p>","DOI":"10.3390\/nu18111796","type":"journal-article","created":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:50:28Z","timestamp":1780447828000},"page":"1796","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Herbal Neurotherapeutics for Cognitive Disorders: Integrative Mechanisms Linking Neurotransmitter Systems, Neurodegeneration, and the Gut-Brain Axis"],"prefix":"10.3390","volume":"18","author":[{"given":"Muntajin","family":"Rahman","sequence":"first","affiliation":[{"name":"Department of Pathology, College of Korean Medicine, Kyung Hee University, Seoul 02453, Republic of Korea"},{"name":"Department of Pharmacy, Northern University Bangladesh, Dakshinkhan, Dhaka 1230, Bangladesh"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khadija","family":"Akter","sequence":"additional","affiliation":[{"name":"Department of Pathology, College of Korean Medicine, Kyung Hee University, Seoul 02453, Republic of Korea"},{"name":"Department of Pharmacy, Northern University Bangladesh, Dakshinkhan, Dhaka 1230, Bangladesh"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amama","family":"Rani","sequence":"additional","affiliation":[{"name":"Department of Pathology, College of Korean Medicine, Kyung Hee University, Seoul 02453, Republic of Korea"},{"name":"Department of Microbiology, Quaid-i-Azam University, Islamabad 45320, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9276-3894","authenticated-orcid":false,"given":"Moon Nyeo","family":"Park","sequence":"additional","affiliation":[{"name":"Department of Pathology, College of Korean Medicine, Kyung Hee University, Seoul 02453, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8678-156X","authenticated-orcid":false,"given":"Bonglee","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Pathology, College of Korean Medicine, Kyung Hee University, Seoul 02453, Republic of Korea"},{"name":"Korean Medicine-Based Drug Repositioning Cancer Research Center, College of Korean Medicine, Kyung Hee University, Seoul 02447, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,6,2]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1212\/WNL.0b013e31828726f5","article-title":"Alzheimer disease in the United States (2010\u20132050) estimated using the 2010 census","volume":"80","author":"Hebert","year":"2013","journal-title":"Neurology"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"P293","DOI":"10.1016\/j.jalz.2016.06.529","article-title":"O3-04-06: Misdiagnosis of Alzheimer\u2019s Disease: Inconsistencies Between Clinical Diagnosis and Neuropathological Confirmation","volume":"12","author":"Qian","year":"2016","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Pais, R., Ruano, L., P. Carvalho, O., and Barros, H. (2020). Global cognitive impairment prevalence and incidence in community dwelling older adults\u2014A systematic review. Geriatrics, 5.","DOI":"10.3390\/geriatrics5040084"},{"key":"ref_4","first-page":"639","article-title":"Cognitive impairment in older adults: Epidemiology, diagnosis, and treatment","volume":"45","author":"Palmer","year":"2022","journal-title":"Psychiatr. Clin."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1007\/s11682-025-01004-x","article-title":"Analysis of the relationship between brain activation and clinical indicators in amnestic mild cognitive impairment","volume":"19","author":"Heo","year":"2025","journal-title":"Brain Imaging Behav."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"S185","DOI":"10.3233\/JAD-2012-111433","article-title":"Type 2 diabetes and cognitive impairment: Linking mechanisms","volume":"30","author":"Luchsinger","year":"2012","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/j.1600-0447.2012.01918.x","article-title":"Mini-Mental Status Examination as predictors of mortality in the elderly","volume":"127","author":"Park","year":"2013","journal-title":"Acta Psychiatr. Scand."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.cger.2013.07.003","article-title":"Classification and epidemiology of MCI","volume":"29","author":"Roberts","year":"2013","journal-title":"Clin. Geriatr. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"119500","DOI":"10.1016\/j.jep.2025.119500","article-title":"The effects of Cheonwangbosim-dan, a traditional herbal medicine prescription, on scopolamine-induced cognitive dysfunction in mice","volume":"343","author":"Park","year":"2025","journal-title":"J. Ethnopharmacol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jpsychires.2021.11.041","article-title":"Prevalence, risk and protective factors for mild cognitive impairment in a population-based study of Singaporean elderly","volume":"145","author":"Liu","year":"2022","journal-title":"J. Psychiatr. Res."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"e14478","DOI":"10.1111\/cns.14478","article-title":"The prevalence and risk factors study of cognitive impairment: Analysis of the elderly population of Han nationality in Hunan province, China","volume":"30","author":"Xu","year":"2024","journal-title":"CNS Neurosci. Ther."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1590\/0101-60830000000197","article-title":"Diagnostic criteria and prevalence of mild cognitive impairment in older adults living in the community: A systematic review and meta-analysis","volume":"46","author":"Pessoa","year":"2019","journal-title":"Arch. Clin. Psychiatry"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Sharma, C., Kim, S., Nam, Y., Jung, U.J., and Kim, S.R. (2021). Mitochondrial dysfunction as a driver of cognitive impairment in Alzheimer\u2019s disease. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22094850"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/nrneurol.2015.251","article-title":"Suspected non-Alzheimer disease pathophysiology\u2014Concept and controversy","volume":"12","author":"Jack","year":"2016","journal-title":"Nat. Rev. Neurol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s00401-019-02004-0","article-title":"The new genetic landscape of Alzheimer\u2019s disease: From amyloid cascade to genetically driven synaptic failure hypothesis?","volume":"138","author":"Dourlen","year":"2019","journal-title":"Acta Neuropathol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1750-1326-8-15","article-title":"Normal cognition in transgenic BRI2-A\u03b2 mice","volume":"8","author":"Kim","year":"2013","journal-title":"Mol. Neurodegener."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Kametani, F., and Hasegawa, M. (2018). Reconsideration of amyloid hypothesis and tau hypothesis in Alzheimer\u2019s disease. Front. Neurosci., 12.","DOI":"10.3389\/fnins.2018.00025"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1515\/revneuro-2017-0006","article-title":"Alzheimer\u2019s disease: As it was in the beginning","volume":"28","author":"Kozlov","year":"2017","journal-title":"Rev. Neurosci."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Chakravorty, A., Jetto, C.T., and Manjithaya, R. (2019). Dysfunctional mitochondria and mitophagy as drivers of Alzheimer\u2019s disease pathogenesis. Front. Aging Neurosci., 11.","DOI":"10.3389\/fnagi.2019.00311"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/bs.irn.2019.03.001","article-title":"Dysfunction of mitochondria: Implications for Alzheimer\u2019s disease","volume":"145","author":"Albensi","year":"2019","journal-title":"Int. Rev. Neurobiol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s10111-022-00715-1","article-title":"Augmenting cognitive work: A review of cognitive enhancement methods and applications for operational domains","volume":"24","author":"Marois","year":"2022","journal-title":"Cogn. Technol. Work"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Mal\u00edk, M., and Tlusto\u0161, P. (2022). Nootropics as cognitive enhancers: Types, dosage and side effects of smart drugs. Nutrients, 14.","DOI":"10.3390\/nu14163367"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.neuropharm.2012.07.002","article-title":"Non-pharmacological cognitive enhancement","volume":"64","author":"Dresler","year":"2013","journal-title":"Neuropharmacology"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Chen, M., Ruan, G., Chen, L., Ying, S., Li, G., Xu, F., Xiao, Z., Tan, Y., Lv, L., and Ping, Y. (2022). Neurotransmitter and intestinal interactions: Focus on the microbiota-gut-brain axis in irritable bowel syndrome. Front. Endocrinol., 13.","DOI":"10.3389\/fendo.2022.817100"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Hamamah, S., Aghazarian, A., Nazaryan, A., Hajnal, A., and Covasa, M. (2022). Role of microbiota-gut-brain axis in regulating dopaminergic signaling. Biomedicines, 10.","DOI":"10.3390\/biomedicines10020436"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Dicks, L.M. (2022). Gut bacteria and neurotransmitters. Microorganisms, 10.","DOI":"10.3390\/microorganisms10091838"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s11739-023-03374-w","article-title":"Gut microbiota, intestinal permeability, and systemic inflammation: A narrative review","volume":"19","author":"Petito","year":"2024","journal-title":"Intern. Emerg. Med."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Mou, Y., Du, Y., Zhou, L., Yue, J., Hu, X., Liu, Y., Chen, S., Lin, X., Zhang, G., and Xiao, H. (2022). Gut microbiota interact with the brain through systemic chronic inflammation: Implications on neuroinflammation, neurodegeneration, and aging. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.796288"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1007\/s11010-022-04471-8","article-title":"The role of short-chain fatty acids in central nervous system diseases","volume":"477","author":"Dong","year":"2022","journal-title":"Mol. Cell. Biochem."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1007\/s11011-025-01554-5","article-title":"Gut microbiota-derived short chain fatty acids act as mediators of the gut-liver-brain axis","volume":"40","author":"Li","year":"2025","journal-title":"Metab. Brain Dis."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"3961","DOI":"10.1080\/10408398.2022.2137776","article-title":"Beneficial effects of butyrate on brain functions: A view of epigenetic","volume":"64","author":"Alpino","year":"2024","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s12017-022-08722-1","article-title":"Implication of paraprobiotics in age-associated gut dysbiosis and neurodegenerative diseases","volume":"25","author":"Rahman","year":"2023","journal-title":"NeuroMol. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1080\/1028415X.2022.2110189","article-title":"The gut microbiome and cognition in Parkinson\u2019s disease: A systematic review","volume":"26","author":"Grant","year":"2023","journal-title":"Nutr. Neurosci."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"110995","DOI":"10.1016\/j.cbi.2024.110995","article-title":"Cannabidiol induces ERK activation and ROS production to promote autophagy and ferroptosis in glioblastoma cells","volume":"394","author":"Kim","year":"2024","journal-title":"Chem.-Biol. Interact."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"105327","DOI":"10.1016\/j.neuint.2022.105327","article-title":"Restoration and targeting of aberrant neurotransmitters in Parkinson\u2019s disease therapeutics","volume":"156","author":"Yadav","year":"2022","journal-title":"Neurochem. Int."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Banerjee, S., McCracken, S., Hossain, M.F., and Slaughter, G. (2020). Electrochemical detection of neurotransmitters. Biosensors, 10.","DOI":"10.3390\/bios10080101"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.molcel.2020.03.006","article-title":"Toward understanding microbiome-neuronal signaling","volume":"78","author":"Jameson","year":"2020","journal-title":"Mol. Cell"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Harilal, S., Kumar, R., Mathew, G.E., Jose, J., Uddin, M.S., and Mathew, B. (2020). Neurochemicals in nervous system and exploring the chemical make-up of human brain. Principles of Neurochemistry, Springer.","DOI":"10.1007\/978-981-15-5167-3_2"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"101558","DOI":"10.1016\/j.arr.2021.101558","article-title":"Exosome: A novel neurotransmission modulator or non-canonical neurotransmitter?","volume":"74","author":"Xia","year":"2022","journal-title":"Ageing Res. Rev."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"107785","DOI":"10.1016\/j.pharmthera.2020.107785","article-title":"Functional and biochemical consequences of disease variants in neurotransmitter transporters: A special emphasis on folding and trafficking deficits","volume":"222","author":"Bhat","year":"2021","journal-title":"Pharmacol. Ther."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Garc\u00eda-Cazorla, \u00c0., and Artuch, R. (2020). Neurotransmitter disorders. Rosenberg\u2019s Molecular and Genetic Basis of Neurological and Psychiatric Disease, Elsevier.","DOI":"10.1016\/B978-0-12-813955-4.00067-2"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s11011-020-00635-x","article-title":"Epilepsy in inherited neurotransmitter disorders: Spotlights on pathophysiology and clinical management","volume":"36","author":"Mastrangelo","year":"2021","journal-title":"Metab. Brain Dis."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/978-981-33-6009-9_5","article-title":"Neurotransmitters and Neurotransmission","volume":"Volume 2","author":"Pichai","year":"2021","journal-title":"Introduction to Basics of Pharmacology and Toxicology"},{"key":"ref_44","first-page":"7468","article-title":"Association of Crocus sativus with cognitive dysfunctions and Alzheimer\u2019s disease: A systematic review","volume":"11","author":"Talebi","year":"2021","journal-title":"Biointerface Res. Appl. Chem."},{"key":"ref_45","first-page":"10739","article-title":"Cholinesterases inhibitory activity of 1H-benzimidazole derivatives","volume":"11","author":"Dinparast","year":"2021","journal-title":"Biointerface Res. Appl. Chem."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"803","DOI":"10.3233\/JAD-210225","article-title":"The burden of Alzheimer\u2019s disease mortality in the United States, 1999\u20132018","volume":"82","author":"Zhao","year":"2021","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"e479","DOI":"10.1016\/S2666-7568(21)00140-9","article-title":"Mortality rates in Alzheimer\u2019s disease and non-Alzheimer\u2019s dementias: A systematic review and meta-analysis","volume":"2","author":"Liang","year":"2021","journal-title":"Lancet Healthy Longev."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Lin, S.-Y., Lin, P.-C., Lin, Y.-C., Lee, Y.-J., Wang, C.-Y., Peng, S.-W., and Wang, P.-N. (2022). The clinical course of early and late mild cognitive impairment. Front. Neurol., 13.","DOI":"10.3389\/fneur.2022.685636"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/s41582-019-0244-7","article-title":"Ageing as a risk factor for neurodegenerative disease","volume":"15","author":"Hou","year":"2019","journal-title":"Nat. Rev. Neurol."},{"key":"ref_50","first-page":"43","article-title":"Molecular genetics of early-and late-onset Alzheimer\u2019s disease","volume":"21","author":"Uddin","year":"2021","journal-title":"Curr. Gene Ther."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"313","DOI":"10.14283\/jpad.2021.15","article-title":"The epidemiology of Alzheimer\u2019s disease modifiable risk factors and prevention","volume":"8","author":"Zhang","year":"2021","journal-title":"J. Prev. Alzheimers Dis."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Adani, G., Filippini, T., Garuti, C., Malavolti, M., Vinceti, G., Zamboni, G., Tondelli, M., Galli, C., Costa, M., and Vinceti, M. (2020). Environmental risk factors for early-onset Alzheimer\u2019s dementia and frontotemporal dementia: A case-control study in northern Italy. Int. J. Environ. Res. Public Health, 17.","DOI":"10.3390\/ijerph17217941"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"5141","DOI":"10.1002\/hbm.25180","article-title":"Women\u2019s brain aging: Effects of sex-hormone exposure, pregnancies, and genetic risk for Alzheimer\u2019s disease","volume":"41","author":"Barth","year":"2020","journal-title":"Hum. Brain Mapp."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s12974-023-02751-8","article-title":"TGF-\u03b21 signalling in Alzheimer\u2019s pathology and cytoskeletal reorganization: A specialized Tau perspective","volume":"20","author":"Kapoor","year":"2023","journal-title":"J. Neuroinflamm."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Urban, A.S., Pavlov, K.V., Kamynina, A.V., Okhrimenko, I.S., Arseniev, A.S., and Bocharov, E.V. (2021). Structural studies providing insights into production and conformational behavior of amyloid-\u03b2 peptide associated with Alzheimer\u2019s disease development. Molecules, 26.","DOI":"10.3390\/molecules26102897"},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Corsi, A., Bombieri, C., Valenti, M.T., and Romanelli, M.G. (2022). Tau isoforms: Gaining insight into MAPT alternative splicing. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms232315383"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s12264-022-00934-6","article-title":"Parkinson\u2019s disease: A multisystem disorder","volume":"39","author":"Costa","year":"2023","journal-title":"Neurosci. Bull."},{"key":"ref_58","first-page":"2076942","article-title":"Cognition deficits in Parkinson\u2019s disease: Mechanisms and treatment","volume":"2020","author":"Fang","year":"2020","journal-title":"Park. Dis."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"117253","DOI":"10.1016\/j.jns.2020.117253","article-title":"Role of mitochondrial dysfunction, oxidative stress and autophagy in progression of Alzheimer\u2019s disease","volume":"421","author":"Bhatia","year":"2021","journal-title":"J. Neurol. Sci."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1152\/physrev.00030.2022","article-title":"Oxidative damage in neurodegeneration: Roles in the pathogenesis and progression of Alzheimer disease","volume":"104","author":"Perluigi","year":"2024","journal-title":"Physiol. Rev."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"101619","DOI":"10.1016\/j.arr.2022.101619","article-title":"Oxidative stress: The core pathogenesis and mechanism of Alzheimer\u2019s disease","volume":"77","author":"Bai","year":"2022","journal-title":"Ageing Res. Rev."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Misrani, A., Tabassum, S., and Yang, L. (2021). Mitochondrial dysfunction and oxidative stress in Alzheimer\u2019s disease. Front. Aging Neurosci., 13.","DOI":"10.3389\/fnagi.2021.617588"},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Pfundstein, G., Nikonenko, A.G., and Sytnyk, V. (2022). Amyloid precursor protein (APP) and amyloid \u03b2 (A\u03b2) interact with cell adhesion molecules: Implications in Alzheimer\u2019s disease and normal physiology. Front. Cell Dev. Biol., 10.","DOI":"10.3389\/fcell.2022.969547"},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Zhang, Y., Wang, M., and Chang, W. (2022). Iron dyshomeostasis and ferroptosis in Alzheimer\u2019s disease: Molecular mechanisms of cell death and novel therapeutic drugs and targets for AD. Front. Pharmacol., 13.","DOI":"10.3389\/fphar.2022.983623"},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Ma, H., Dong, Y., Chu, Y., Guo, Y., and Li, L. (2022). The mechanisms of ferroptosis and its role in alzheimer\u2019s disease. Front. Mol. Biosci., 9.","DOI":"10.3389\/fmolb.2022.965064"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1152\/physrev.00038.2021","article-title":"ER-phagy: Mechanisms, regulation, and diseases connected to the lysosomal clearance of the endoplasmic reticulum","volume":"102","author":"Reggiori","year":"2022","journal-title":"Physiol. Rev."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"5379","DOI":"10.1007\/s12035-022-02897-1","article-title":"Role of ubiquitin\u2013proteasome and autophagy-lysosome pathways in \u03b1-synuclein aggregate clearance","volume":"59","author":"Sahoo","year":"2022","journal-title":"Mol. Neurobiol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1042\/BST20220830","article-title":"The role of the blood\u2013brain barrier during neurological disease and infection","volume":"51","author":"Patabendige","year":"2023","journal-title":"Biochem. Soc. Trans."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1161\/STROKEAHA.122.040578","article-title":"Blood-brain barrier dysfunction in normal aging and neurodegeneration: Mechanisms, impact, and treatments","volume":"54","author":"Andjelkovic","year":"2023","journal-title":"Stroke"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1007\/s13760-024-02706-7","article-title":"Brain insulin resistance mediated cognitive impairment and neurodegeneration: Type-3 diabetes or Alzheimer\u2019s Disease","volume":"125","author":"Ahlawat","year":"2025","journal-title":"Acta Neurol. Belg."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s13195-022-00996-8","article-title":"Glucose metabolism and AD: Evidence for a potential diabetes type 3","volume":"14","author":"Churruca","year":"2022","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s44446-025-00026-2","article-title":"Non-coding RNA-mediated gene regulation in Alzheimer\u2019s disease pathogenesis: Molecular insights and emerging innovations","volume":"33","author":"Alzarea","year":"2025","journal-title":"Saudi Pharm. J."},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Lossi, L., Castagna, C., and Merighi, A. (2024). An overview of the epigenetic modifications in the brain under normal and pathological conditions. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25073881"},{"key":"ref_74","unstructured":"Mehder, R.H. (2020). Neuronal Oxidative Stress and Dendritic Trimming in a Mouse Model of Late Onset Alzheimer\u2019s Disease. [Ph.D. Thesis, Queen\u2019s University]."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"100002","DOI":"10.1016\/j.jnrt.2022.100002","article-title":"Acetylcholine bidirectionally regulates learning and memory","volume":"10","author":"Huang","year":"2022","journal-title":"J. Neurorestoratology"},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Bekdash, R.A. (2021). The cholinergic system, the adrenergic system and the neuropathology of Alzheimer\u2019s disease. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22031273"},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Gunday, E., and Deniz, F.S.S. (2026). Alzheimer\u2019s Disease and Contemporary Therapeutic Approaches: Recent Advances in Natural Products. Drugs Drug Candidates, 5.","DOI":"10.3390\/ddc5010021"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.brainresbull.2019.01.004","article-title":"Recent therapeutic strategies targeting beta amyloid and tauopathies in Alzheimer\u2019s disease","volume":"146","author":"Madav","year":"2019","journal-title":"Brain Res. Bull."},{"key":"ref_79","unstructured":"Roy, P. (2023). Cerebrovascular Disease Related to Hypertension: Effects of Antioxidant and Cholinergic Precursor Molecules. [Ph.D. Thesis, University of Camerino]."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13024-020-00376-6","article-title":"Mitochondria dysfunction in the pathogenesis of Alzheimer\u2019s disease: Recent advances","volume":"15","author":"Wang","year":"2020","journal-title":"Mol. Neurodegener."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s12640-020-00198-w","article-title":"Effects of prolonged seizures on basal forebrain cholinergic neurons: Evidence and potential clinical relevance","volume":"38","author":"Giorgi","year":"2020","journal-title":"Neurotox. Res."},{"key":"ref_82","first-page":"CD001190","article-title":"Donepezil for dementia due to Alzheimer\u2019s disease","volume":"6","author":"Govind","year":"2020","journal-title":"Br. J. Community Nurs."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"41","DOI":"10.2165\/00003495-200161010-00005","article-title":"Cholinesterase inhibitors for Alzheimer\u2019s disease","volume":"61","author":"Grutzendler","year":"2001","journal-title":"Drugs"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3233\/ADR-210061","article-title":"Neuroprotective effects of cholinesterase inhibitors: Current scenario in therapies for Alzheimer\u2019s disease and future perspectives","volume":"6","author":"Moreira","year":"2022","journal-title":"J. Alzheimer\u2019s Dis. Rep."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1177\/1756285612461679","article-title":"Current and future treatments for Alzheimer\u2019s disease","volume":"6","author":"Yiannopoulou","year":"2013","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Bayo Jimenez, M.T., Rivas-Garc\u00eda, L., S\u00e1nchez-Gonz\u00e1lez, C., Grosso, G., Lipari, V., Vera-Ram\u00edrez, L., Battino, M., Giampieri, F., Quiles, J.L., and Forbes-Hern\u00e1ndez, T.Y. (2025). Natural Products in Alzheimer\u2019s Disease: A Systematic Review of Clinical Trials and Underlying Molecular Mechanisms. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms262110631"},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Nahar, L., Charoensup, R., Kalieva, K., Habibi, E., Guo, M., Wang, D., Kvasnica, M., Onder, A., and Sarker, S. (2025). Natural products in neurodegenerative diseases: Recent advances and future outlook. Front. Pharmacol., 16.","DOI":"10.3389\/fphar.2025.1529194"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"3","DOI":"10.14283\/jpad.2022.9","article-title":"Mechanisms underlying non-pharmacological dementia prevention strategies: A translational perspective","volume":"9","author":"Alanko","year":"2022","journal-title":"J. Prev. Alzheimer\u2019s Dis."},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Direito, R., Barbalho, S.M., Sepodes, B., and Figueira, M.E. (2024). Plant-derived bioactive compounds: Exploring neuroprotective, metabolic, and hepatoprotective effects for health promotion and disease prevention. Pharmaceutics, 16.","DOI":"10.20944\/preprints202402.0641.v1"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"11795735211029113","DOI":"10.1177\/11795735211029113","article-title":"The state of the art on acetylcholinesterase inhibitors in the treatment of Alzheimer\u2019s disease","volume":"13","author":"Vecchio","year":"2021","journal-title":"J. Cent. Nerv. Syst. Dis."},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Cheng, Y.-J., Lin, C.-H., and Lane, H.-Y. (2021). Involvement of cholinergic, adrenergic, and glutamatergic network modulation with cognitive dysfunction in Alzheimer\u2019s disease. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22052283"},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Yang, Z., Zou, Y., and Wang, L. (2023). Neurotransmitters in prevention and treatment of Alzheimer\u2019s disease. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24043841"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1080\/13543776.2025.2602702","article-title":"An updated patent review of acetylcholinesterase inhibitors for the treatment of alzheimer\u2019s disease (2021\u2013present)","volume":"36","author":"Begines","year":"2026","journal-title":"Expert Opin. Ther. Pat."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"108352","DOI":"10.1016\/j.neuropharm.2020.108352","article-title":"Efficacy of acetylcholinesterase inhibitors in Alzheimer\u2019s disease","volume":"190","author":"Marucci","year":"2021","journal-title":"Neuropharmacology"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1080\/14740338.2020.1721456","article-title":"An update on the utility and safety of cholinesterase inhibitors for the treatment of Alzheimer\u2019s disease","volume":"19","author":"Haake","year":"2020","journal-title":"Expert Opin. Drug Saf."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"703","DOI":"10.2174\/1389557520666200103100521","article-title":"Potent acetylcholinesterase inhibitors: Potential drugs for Alzheimer\u2019s disease","volume":"20","year":"2020","journal-title":"Mini Rev. Med. Chem."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1001\/jamaneurol.2023.1835","article-title":"Cholinesterase inhibitors for treatment of psychotic symptoms in Alzheimer disease and Parkinson disease: A meta-analysis","volume":"80","author":"Begemann","year":"2023","journal-title":"JAMA Neurol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1080\/14728214.2024.2363215","article-title":"Emerging therapies for treatment of agitation, psychosis, or apathy in Alzheimer\u2019s disease","volume":"29","author":"Wang","year":"2024","journal-title":"Expert Opin. Emerg. Drugs"},{"key":"ref_99","first-page":"13872877261431692","article-title":"Efficacy and safety of Woohwangchungsimwon in combination with donepezil for behavioral and psychological symptoms of dementia in probable Alzheimer\u2019s disease: An assessor-blinded randomized controlled trial","volume":"111","author":"Kim","year":"2026","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1080\/14740338.2025.2576520","article-title":"Tolerability of rivastigmine transdermal patch in patients with Alzheimer\u2019s disease: A narrative review","volume":"25","year":"2026","journal-title":"Expert Opin. Drug Saf."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"119099","DOI":"10.1016\/j.biopha.2026.119099","article-title":"Novel short-acting non-depolarizing muscle relaxants derived from galantamine: Design, synthesis, and pharmacological evaluation","volume":"196","author":"Rouleau","year":"2026","journal-title":"Biomed. Pharmacother."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"128","DOI":"10.5603\/pjnns.109190","article-title":"Alzheimer\u2019s disease: A clinical update on diagnosis and treatment","volume":"60","author":"Shir","year":"2026","journal-title":"Neurol. I Neurochir. Pol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1177\/10738584211011979","article-title":"Non-motor symptoms of Parkinson\u2019s disease: The neurobiology of early psychiatric and cognitive dysfunction","volume":"29","author":"Hussein","year":"2023","journal-title":"Neuroscientist"},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Eichel, H.v., Heine, J., Wegner, F., Rogozinski, S., Stiel, S., Groh, A., Krey, L., H\u00f6glinger, G.U., and Klietz, M. (2022). Neuropsychiatric symptoms in Parkinson\u2019s disease patients are associated with reduced health-related quality of life and increased caregiver burden. Brain Sci., 12.","DOI":"10.3390\/brainsci12010089"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1148\/radiol.2021203341","article-title":"Imaging the substantia nigra in Parkinson disease and other Parkinsonian syndromes","volume":"300","author":"Bae","year":"2021","journal-title":"Radiology"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.bbapap.2019.05.003","article-title":"\u03b1-Synuclein aggregation at low concentrations","volume":"1867","author":"Afitska","year":"2019","journal-title":"Biochim. Biophys. Acta (BBA)-Proteins Proteom."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1007\/s12031-020-01776-5","article-title":"Tau in the pathophysiology of Parkinson\u2019s disease","volume":"71","author":"Pan","year":"2021","journal-title":"J. Mol. Neurosci."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"105760","DOI":"10.1016\/j.neuint.2024.105760","article-title":"The Misfolding Mystery: \u03b1-syn and the Pathogenesis of Parkinson\u2019s Disease","volume":"177","author":"Negi","year":"2024","journal-title":"Neurochem. Int."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.tins.2018.11.001","article-title":"Synaptic, mitochondrial, and lysosomal dysfunction in Parkinson\u2019s disease","volume":"42","author":"Nguyen","year":"2019","journal-title":"Trends Neurosci."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"E2634","DOI":"10.1073\/pnas.1713849115","article-title":"Identification of a highly neurotoxic \u03b1-synuclein species inducing mitochondrial damage and mitophagy in Parkinson\u2019s disease","volume":"115","author":"Grassi","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1126\/science.aam9080","article-title":"Dopamine oxidation mediates mitochondrial and lysosomal dysfunction in Parkinson\u2019s disease","volume":"357","author":"Burbulla","year":"2017","journal-title":"Science"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1152\/jn.00681.2017","article-title":"Abnormal visual gain control and excitotoxicity in early-onset Parkinson\u2019s disease Drosophila models","volume":"119","author":"Himmelberg","year":"2018","journal-title":"J. Neurophysiol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"84","DOI":"10.4103\/0973-7847.194044","article-title":"Overviews of biological importance of quercetin: A bioactive flavonoid","volume":"10","author":"Arulmoli","year":"2016","journal-title":"Pharmacogn. Rev."},{"key":"ref_114","doi-asserted-by":"crossref","unstructured":"Mekhalfi, M., and Berteina-Raboin, S. (2026). Mucuna pruriens: A Dietary Supplement with Balancing Properties That Can Limit Neurological Disorders and Associated Depressive States. Sci. Pharm., 94.","DOI":"10.3390\/scipharm94010016"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"520","DOI":"10.2174\/1568026615666150813143520","article-title":"Ginkgo biloba for mild cognitive impairment and Alzheimer\u2019s disease: A systematic review and meta-analysis of randomized controlled trials","volume":"16","author":"Yang","year":"2016","journal-title":"Curr. Top. Med. Chem."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/ene.14108","article-title":"Parkinson disease","volume":"27","author":"Balestrino","year":"2020","journal-title":"Eur. J. Neurol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/s41540-020-00150-w","article-title":"ROS networks: Designs, aging, Parkinson\u2019s disease and precision therapies","volume":"6","author":"Kolodkin","year":"2020","journal-title":"npj Syst. Biol. Appl."},{"key":"ref_118","doi-asserted-by":"crossref","unstructured":"Pervin, M., Unno, K., Ohishi, T., Tanabe, H., Miyoshi, N., and Nakamura, Y. (2018). Beneficial effects of green tea catechins on neurodegenerative diseases. Molecules, 23.","DOI":"10.3390\/molecules23061297"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1001\/jama.2019.22360","article-title":"Diagnosis and treatment of Parkinson disease: A review","volume":"323","author":"Armstrong","year":"2020","journal-title":"JAMA"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/s41531-022-00277-z","article-title":"Safinamide in the treatment pathway of Parkinson\u2019s disease: A European Delphi consensus","volume":"8","author":"Stocchi","year":"2022","journal-title":"npj Park. Dis."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1002\/mds.27360","article-title":"Disease modification in Parkinson\u2019s disease: Current approaches, challenges, and future considerations","volume":"33","author":"Lang","year":"2018","journal-title":"Mov. Disord."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S1474-4422(21)00061-2","article-title":"Progress towards therapies for disease modification in Parkinson\u2019s disease","volume":"20","author":"Vijiaratnam","year":"2021","journal-title":"Lancet Neurol."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1177\/1545968320952799","article-title":"Physiotherapy in Parkinson\u2019s disease: A meta-analysis of present treatment modalities","volume":"34","author":"Radder","year":"2020","journal-title":"Neurorehabilit. Neural Repair"},{"key":"ref_124","doi-asserted-by":"crossref","unstructured":"Nuzzo, D. (2021). Role of natural antioxidants on neuroprotection and neuroinflammation. Antioxidants, 10.","DOI":"10.3390\/antiox10040608"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1212\/WNL.0000000000004175","article-title":"Mucuna pruriens in Parkinson disease: A double-blind, randomized, controlled, crossover study","volume":"89","author":"Cilia","year":"2017","journal-title":"Neurology"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12986-024-00800-4","article-title":"Natural products in the management of neurodegenerative diseases","volume":"21","author":"Goyal","year":"2024","journal-title":"Nutr. Metab."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1016\/j.drudis.2019.05.003","article-title":"The current status of pharmacotherapy for the treatment of Parkinson\u2019s disease: Transition from single-target to multitarget therapy","volume":"24","author":"Cheong","year":"2019","journal-title":"Drug Discov. Today"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1097\/WCO.0000000000000579","article-title":"Update in therapeutic strategies for Parkinson\u2019s disease","volume":"31","author":"Kulisevsky","year":"2018","journal-title":"Curr. Opin. Neurol."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1080\/14737175.2023.2173576","article-title":"Treatment for cognitive and neuropsychiatric non-motor symptoms in Parkinson\u2019s disease: Current evidence and future perspectives","volume":"23","author":"Mantovani","year":"2023","journal-title":"Expert Rev. Neurother."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1007\/s40263-020-00754-0","article-title":"Non-dopaminergic treatments for motor control in Parkinson\u2019s disease: An update","volume":"34","author":"Bhowmick","year":"2020","journal-title":"CNS Drugs"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.2174\/1570159X20666220222150811","article-title":"An Update on Nondopaminergic Treatments for Motor and Non-motor symptoms of Parkinson\u2019s disease","volume":"21","author":"Jing","year":"2023","journal-title":"Curr. Neuropharmacol."},{"key":"ref_132","first-page":"37023","article-title":"Aduhelm, a novel anti-amyloid monoclonal antibody, for the treatment of Alzheimer\u2019s disease: A comprehensive review","volume":"10","author":"Haddad","year":"2022","journal-title":"Health Psychol. Res."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1001\/jamainternmed.2021.4607","article-title":"Approval of aducanumab for Alzheimer disease\u2014The FDA\u2019s perspective","volume":"181","author":"Dunn","year":"2021","journal-title":"JAMA Intern. Med."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1021\/acsptsci.9b00110","article-title":"The discovery of suvorexant: Lessons learned that can be applied to other CNS drug development efforts","volume":"3","author":"Uslaner","year":"2020","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"566","DOI":"10.25259\/JNRP_356_2023","article-title":"Guidelines for pharmacotherapy in Alzheimer\u2019s disease\u2013A primer on FDA-approved drugs","volume":"14","author":"Varadharajan","year":"2023","journal-title":"J. Neurosci. Rural Pract."},{"key":"ref_136","first-page":"1642","article-title":"First donepezil transdermal patch approved for Alzheimer disease","volume":"327","author":"Larkin","year":"2022","journal-title":"JAMA"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"e10367","DOI":"10.1002\/btm2.10367","article-title":"Alzheimer\u2019s and Parkinson\u2019s disease therapies in the clinic","volume":"8","author":"Chopade","year":"2023","journal-title":"Bioeng. Transl. Med."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"943","DOI":"10.17219\/acem\/171379","article-title":"Lecanemab (Leqembi) is not the right drug for patients with Alzheimer\u2019s disease","volume":"32","author":"Kurkinen","year":"2023","journal-title":"Adv. Clin. Exp. Med."},{"key":"ref_139","first-page":"428","article-title":"Lecanemab Unveiled: Exploring Alzheimer\u2019s Treatment Advancements, Assessing Strengths, Limitations, and Its Therapeutic Landscape Position","volume":"37","author":"Adepoju","year":"2024","journal-title":"Biomed. Environ. Sci."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.2165\/00003495-200666110-00015","article-title":"Memantine: A review of its use in Alzheimer\u2019s disease","volume":"66","author":"Robinson","year":"2006","journal-title":"Drugs"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2217\/nmt-2020-0052","article-title":"Evaluation of rivastigmine in Alzheimer\u2019s disease","volume":"11","author":"Nguyen","year":"2021","journal-title":"Neurodegener. Dis. Manag."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"103305","DOI":"10.1016\/j.drudis.2022.06.005","article-title":"Emerging therapeutic developments in neurodegenerative diseases: A clinical investigation","volume":"27","author":"Kumar","year":"2022","journal-title":"Drug Discov. Today"},{"key":"ref_143","doi-asserted-by":"crossref","unstructured":"Laifenfeld, D., Yanover, C., Ozery-Flato, M., Shaham, O., Rosen-Zvi, M., Lev, N., Goldschmidt, Y., and Grossman, I. (2021). Emulated clinical trials from longitudinal real-world data efficiently identify candidates for neurological disease modification: Examples from parkinson\u2019s disease. Front. Pharmacol., 12.","DOI":"10.3389\/fphar.2021.631584"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"e81","DOI":"10.1016\/j.nurpra.2015.10.020","article-title":"Parkinson\u2019s disease: Update on medication management","volume":"12","year":"2016","journal-title":"J. Nurse Pract."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1080\/14737175.2021.1968298","article-title":"Redefining the strategy for the use of COMT inhibitors in Parkinson\u2019s disease: The role of opicapone","volume":"21","author":"Jenner","year":"2021","journal-title":"Expert Rev. Neurother."},{"key":"ref_146","unstructured":"Meglio, M. (Neurology Live, 2023). FDA Issues Complete Response Letter for AbbVie\u2019s 24-Hour Continuous Carbidopa\/Levodopa Pump, Neurology Live."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s40120-021-00246-3","article-title":"Effects of Gocovri (amantadine) extended release capsules on non-motor symptoms in patients with Parkinson\u2019s disease and dyskinesia","volume":"10","author":"Mehta","year":"2021","journal-title":"Neurol. Ther."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1080\/17425247.2021.1960820","article-title":"A technology evaluation of CVT-301 (Inbrija): An inhalable therapy for treatment of Parkinson\u2019s disease","volume":"18","author":"Lipp","year":"2021","journal-title":"Expert Opin. Drug Deliv."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/s40120-021-00251-6","article-title":"Pharmacokinetics and comparative bioavailability of apomorphine sublingual film and subcutaneous apomorphine formulations in patients with Parkinson\u2019s disease and \u201cOFF\u201d episodes: Results of a randomized, three-way crossover, open-label study","volume":"10","author":"Agbo","year":"2021","journal-title":"Neurol. Ther."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1021\/acschemneuro.0c00332","article-title":"Classics in chemical neuroscience: Pramipexole","volume":"11","author":"Wilson","year":"2020","journal-title":"ACS Chem. Neurosci."},{"key":"ref_151","first-page":"757","article-title":"Parkinson\u2019s disease drug therapies in the clinical trial pipeline: 2020","volume":"10","author":"McFarthing","year":"2020","journal-title":"J. Park. Dis."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1177\/1060028020974560","article-title":"Opicapone (Ongentys): A New COMT Inhibitor for the Treatment of Parkinson\u2019s Disease","volume":"55","author":"Vanderhoof","year":"2021","journal-title":"Ann. Pharmacother."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1007\/s13311-020-00889-4","article-title":"Medical management and prevention of motor complications in Parkinson\u2019s disease","volume":"17","author":"Aradi","year":"2020","journal-title":"Neurotherapeutics"},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1001\/jamaneurol.2023.2679","article-title":"IPX203 vs immediate-release carbidopa-levodopa for the treatment of motor fluctuations in Parkinson disease: The RISE-PD randomized clinical trial","volume":"80","author":"Hauser","year":"2023","journal-title":"JAMA Neurol."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1007\/s00415-022-10963-w","article-title":"Levodopa-induced dyskinesia: A historical review of Parkinson\u2019s disease, dopamine, and modern advancements in research and treatment","volume":"269","author":"Hansen","year":"2022","journal-title":"J. Neurol."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/wps.20229","article-title":"What has serotonin to do with depression?","volume":"14","author":"Cowen","year":"2015","journal-title":"World Psychiatry"},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1515\/revneuro-2013-0026","article-title":"5-HT systems: Emergent targets for memory formation and memory alterations","volume":"24","author":"Meneses","year":"2013","journal-title":"Rev. Neurosci."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"141","DOI":"10.5498\/wjp.v13.i4.141","article-title":"Kynurenine pathway of tryptophan metabolism in pathophysiology and therapy of major depressive disorder","volume":"13","author":"Badawy","year":"2023","journal-title":"World J. Psychiatry"},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.pharmthera.2012.09.006","article-title":"Serotonin receptors involved in antidepressant effects","volume":"137","author":"Artigas","year":"2013","journal-title":"Pharmacol. Ther."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0091-3057(01)00746-8","article-title":"Molecular, pharmacological and functional diversity of 5-HT receptors","volume":"71","author":"Hoyer","year":"2002","journal-title":"Pharmacol. Biochem. Behav."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"7043213","DOI":"10.1155\/2018\/7043213","article-title":"Flavonoids as therapeutic agents in Alzheimer\u2019s and Parkinson\u2019s diseases: A systematic review of preclinical evidences","volume":"2018","author":"Diniz","year":"2018","journal-title":"Oxidative Med. Cell. Longev."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1177\/0269881117725915","article-title":"Serotonin and brain function: A tale of two receptors","volume":"31","author":"Nutt","year":"2017","journal-title":"J. Psychopharmacol."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1159\/000447034","article-title":"The safety, tolerability and risks associated with the use of newer generation antidepressant drugs: A critical review of the literature","volume":"85","author":"Carvalho","year":"2016","journal-title":"Psychother. Psychosom."},{"key":"ref_164","doi-asserted-by":"crossref","unstructured":"Kern, D.M., Cepeda, M.S., Defalco, F., and Etropolski, M. (2020). Treatment patterns and sequences of pharmacotherapy for patients diagnosed with depression in the United States: 2014 through 2019. BMC Psychiatry, 20.","DOI":"10.1186\/s12888-019-2418-7"},{"key":"ref_165","doi-asserted-by":"crossref","unstructured":"Yu, Z., Zhang, J., Zheng, Y., and Yu, L. (2020). Trends in antidepressant use and expenditure in six major cities in China from 2013 to 2018. Front. Psychiatry, 11.","DOI":"10.3389\/fpsyt.2020.00551"},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1093\/ijnp\/pyx070","article-title":"A network meta-analysis comparing effects of various antidepressant classes on the digit symbol substitution test (DSST) as a measure of cognitive dysfunction in patients with major depressive disorder","volume":"21","author":"Baune","year":"2018","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"ref_167","doi-asserted-by":"crossref","unstructured":"Mickymaray, S. (2019). Efficacy and mechanism of traditional medicinal plants and bioactive compounds against clinically important pathogens. Antibiotics, 8.","DOI":"10.3390\/antibiotics8040257"},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"22458","DOI":"10.1021\/acsomega.6c00495","article-title":"Plant-Derived Peptides with Neuroprotective Activity: Advances and Perspectives in the Prevention of Neurodegenerative Diseases","volume":"11","author":"Maia","year":"2026","journal-title":"ACS Omega"},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1001\/jamapsychiatry.2019.3360","article-title":"Schizophrenia\u2014An overview","volume":"77","author":"McCutcheon","year":"2020","journal-title":"JAMA Psychiatry"},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.schres.2018.08.018","article-title":"Positive and negative symptoms in schizophrenia: A longitudinal analysis using latent variable structural equation modelling","volume":"204","author":"Crocamo","year":"2019","journal-title":"Schizophr. Res."},{"key":"ref_171","doi-asserted-by":"crossref","unstructured":"Chang, C.-Y., Luo, D.-Z., Pei, J.-C., Kuo, M.-C., Hsieh, Y.-C., and Lai, W.-S. (2021). Not just a bystander: The emerging role of astrocytes and research tools in studying cognitive dysfunctions in schizophrenia. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22105343"},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"16","DOI":"10.26599\/JFB.2026.95033436","article-title":"Aromatic plant-derived essential oils: Bioactive compounds and their neuroprotective functions in neurological health","volume":"33","author":"Ni","year":"2026","journal-title":"J. Food Bioact."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1093\/schbul\/sbx178","article-title":"Mapping convergent and divergent cortical thinning patterns in patients with deficit and nondeficit schizophrenia","volume":"45","author":"Xie","year":"2019","journal-title":"Schizophr. Bull."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"109907","DOI":"10.1016\/j.pnpbp.2020.109907","article-title":"Identificacion of MRI-based psychosis subtypes: Replication and refinement","volume":"100","author":"Lubeiro","year":"2020","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"102131","DOI":"10.1016\/j.nicl.2019.102131","article-title":"Structural abnormality in schizophrenia versus bipolar disorder: A whole brain cortical thickness, surface area, volume and gyrification analyses","volume":"25","author":"Madre","year":"2020","journal-title":"NeuroImage Clin."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1016\/j.jacc.2020.03.053","article-title":"Associations between cardiovascular risk, structural brain changes, and cognitive decline","volume":"75","author":"Song","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/s41386-021-01089-0","article-title":"Mechanisms underlying dorsolateral prefrontal cortex contributions to cognitive dysfunction in schizophrenia","volume":"47","author":"Smucny","year":"2022","journal-title":"Neuropsychopharmacology"},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"4463","DOI":"10.1093\/cercor\/bhy306","article-title":"Schizophrenia exhibits bi-directional brain-wide alterations in cortico-striato-cerebellar circuits","volume":"29","author":"Ji","year":"2019","journal-title":"Cereb. Cortex"},{"key":"ref_179","first-page":"496","article-title":"Effects of Stress and Cortisol on the Brain Behavioral Functions: Mood and Memory","volume":"35","author":"Hawiset","year":"2020","journal-title":"Srinagarind Med. J."},{"key":"ref_180","doi-asserted-by":"crossref","unstructured":"Mart\u00ednez, A.L., Brea, J., Rico, S., De los Frailes, M.T., and Loza, M.I. (2021). Cognitive deficit in schizophrenia: From etiology to novel treatments. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22189905"},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1159\/000502143","article-title":"Association between BDNF polymorphism and hypothalamic-pituitary-adrenal activity in later adulthood","volume":"66","author":"Fiocco","year":"2020","journal-title":"Gerontology"},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.psyneuen.2018.11.028","article-title":"The role of cortisol and prolactin in the pathogenesis and clinical expression of psychotic disorders","volume":"102","author":"Labad","year":"2019","journal-title":"Psychoneuroendocrinology"},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1159\/000521653","article-title":"Associations between Prolactin, Diabetes, and Cognitive Impairment: A literature review","volume":"112","author":"Oh","year":"2022","journal-title":"Neuroendocrinology"},{"key":"ref_184","doi-asserted-by":"crossref","unstructured":"Chien, H.-Y., Chen, S.-M., and Li, W.-C. (2023). Dopamine receptor agonists mechanism of actions on glucose lowering and their connections with prolactin actions. Front. Clin. Diabetes Healthc., 4.","DOI":"10.3389\/fcdhc.2023.935872"},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.48129\/kjs.v48i2.9264","article-title":"Role of neurotransmitters in schizophrenia: A comprehensive study","volume":"48","author":"Bansal","year":"2021","journal-title":"Kuwait J. Sci."},{"key":"ref_186","doi-asserted-by":"crossref","unstructured":"Teleanu, R.I., Niculescu, A.-G., Roza, E., Vlad\u00e2cenco, O., Grumezescu, A.M., and Teleanu, D.M. (2022). Neurotransmitters\u2014Key factors in neurological and neurodegenerative disorders of the central nervous system. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23115954"},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"100015","DOI":"10.1016\/j.bionps.2020.100015","article-title":"Prefrontal cortical alterations of glutamate and GABA neurotransmission in schizophrenia: Insights for rational biomarker development","volume":"3","author":"Schoonover","year":"2020","journal-title":"Biomark. Neuropsychiatry"},{"key":"ref_188","doi-asserted-by":"crossref","unstructured":"Shu, I.-W., Granholm, E.L., and Singh, F. (2022). Targeting frontal gamma activity with neurofeedback to improve working memory in schizophrenia. Cognitive Functioning in Schizophrenia: Leveraging the RDoC Framework, Springer.","DOI":"10.1007\/7854_2022_377"},{"key":"ref_189","doi-asserted-by":"crossref","unstructured":"Zhang, T., Liu, C., Zhong, N., Wang, Y., Huang, Y., and Zhang, X. (2024). Advances in the treatment of cognitive impairment in schizophrenia: Targeting NMDA receptor pathways. Int. J. Mol. Sci., 25.","DOI":"10.20944\/preprints202408.1626.v1"},{"key":"ref_190","doi-asserted-by":"crossref","unstructured":"Billard, J.-M. (2018). Changes in serine racemase-dependent modulation of NMDA receptor: Impact on physiological and pathological brain aging. Front. Mol. Biosci., 5.","DOI":"10.3389\/fmolb.2018.00106"},{"key":"ref_191","doi-asserted-by":"crossref","unstructured":"Pei, J.-C., Luo, D.-Z., Gau, S.-S., Chang, C.-Y., and Lai, W.-S. (2021). Directly and indirectly targeting the glycine modulatory site to modulate NMDA receptor function to address unmet medical needs of patients with schizophrenia. Front. Psychiatry, 12.","DOI":"10.3389\/fpsyt.2021.742058"},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"2860","DOI":"10.1038\/s41380-019-0401-9","article-title":"Dysregulation of kynurenine metabolism is related to proinflammatory cytokines, attention, and prefrontal cortex volume in schizophrenia","volume":"25","author":"Kindler","year":"2020","journal-title":"Mol. Psychiatry"},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"106258","DOI":"10.1016\/j.phrs.2022.106258","article-title":"Cannabis induced psychosis: A systematic review on the role of genetic polymorphisms","volume":"181","author":"Carvalho","year":"2022","journal-title":"Pharmacol. Res."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/s41398-022-02253-w","article-title":"Glutamatergic dysfunction in Schizophrenia","volume":"12","author":"Kruse","year":"2022","journal-title":"Transl. Psychiatry"},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1176\/appi.ajp.2020.20101481","article-title":"Fifty years of research on schizophrenia: The ascendance of the glutamatergic synapse","volume":"177","author":"Coyle","year":"2020","journal-title":"Am. J. Psychiatry"},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s00213-003-1582-z","article-title":"NMDA receptor antagonist effects, cortical glutamatergic function, and schizophrenia: Toward a paradigm shift in medication development","volume":"169","author":"Krystal","year":"2003","journal-title":"Psychopharmacology"},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/wps.20693","article-title":"Dopamine and glutamate in schizophrenia: Biology, symptoms and treatment","volume":"19","author":"McCutcheon","year":"2020","journal-title":"World Psychiatry"},{"key":"ref_198","doi-asserted-by":"crossref","unstructured":"Adell, A. (2020). Brain NMDA receptors in schizophrenia and depression. Biomolecules, 10.","DOI":"10.3390\/biom10060947"},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/npp.2011.181","article-title":"From revolution to evolution: The glutamate hypothesis of schizophrenia and its implication for treatment","volume":"37","author":"Moghaddam","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"111453","DOI":"10.1016\/j.biopha.2021.111453","article-title":"Therapeutic potentiality of a new flavonoid against ketamine induced glutamatergic dysregulation in schizophrenia: In vivo and in silico approach","volume":"138","author":"Venkataramaiah","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"bhae319","DOI":"10.1093\/cercor\/bhae319","article-title":"GABA system in the prefrontal cortex involved in psychostimulant addiction","volume":"34","author":"Shi","year":"2024","journal-title":"Cereb. Cortex"},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/s41583-019-0141-5","article-title":"Preserving the balance: Diverse forms of long-term GABAergic synaptic plasticity","volume":"20","author":"Chiu","year":"2019","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.semcdb.2021.01.005","article-title":"GABAergic dysfunction, neural network hyperactivity and memory impairments in human aging and Alzheimer\u2019s disease","volume":"116","author":"Eich","year":"2021","journal-title":"Semin. Cell Dev. Biol."},{"key":"ref_204","doi-asserted-by":"crossref","unstructured":"Liwinski, T., Lang, U.E., Br\u00fchl, A.B., and Schneider, E. (2023). Exploring the therapeutic potential of gamma-aminobutyric acid in stress and depressive disorders through the gut\u2013brain axis. Biomedicines, 11.","DOI":"10.20944\/preprints202310.1508.v1"},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41380-020-0727-3","article-title":"Altered GABA-mediated information processing and cognitive dysfunctions in depression and other brain disorders","volume":"26","author":"Sibille","year":"2021","journal-title":"Mol. Psychiatry"},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"173531","DOI":"10.1016\/j.ejphar.2020.173531","article-title":"GABAB receptor intracellular signaling: Novel pathways for depressive disorder treatment?","volume":"885","author":"Korczak","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"19159","DOI":"10.1074\/jbc.CL118.006591","article-title":"The discovery of GABA in the brain","volume":"293","author":"Spiering","year":"2018","journal-title":"J. Biol. Chem."},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/s41583-021-00540-x","article-title":"The stressed synapse 2.0: Pathophysiological mechanisms in stress-related neuropsychiatric disorders","volume":"23","author":"Sanacora","year":"2022","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"747835","DOI":"10.3389\/fnmol.2021.747835","article-title":"When are depolarizing GABAergic responses excitatory?","volume":"14","author":"Kilb","year":"2021","journal-title":"Front. Mol. Neurosci."},{"key":"ref_210","doi-asserted-by":"crossref","unstructured":"Rocha, L., Alonso-Vanegas, M., Mart\u00ednez-Ju\u00e1rez, I.E., Orozco-Su\u00e1rez, S., Escalante-Santiago, D., Feria-Romero, I.A., Zavala-Tecuapetla, C., Cisneros-Franco, J.M., Buentello-Garc\u00eda, R.M., and Cienfuegos, J. (2015). GABAergic alterations in neocortex of patients with pharmacoresistant temporal lobe epilepsy can explain the comorbidity of anxiety and depression: The potential impact of clinical factors. Front. Cell. Neurosci., 8.","DOI":"10.3389\/fncel.2014.00442"},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"3337","DOI":"10.1002\/hbm.23244","article-title":"Brain GABA levels across psychiatric disorders: A systematic literature review and meta-analysis of 1H-MRS studies","volume":"37","author":"Draisma","year":"2016","journal-title":"Hum. Brain Mapp."},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.jad.2020.06.050","article-title":"The effect of intravenous, intranasal, and oral ketamine in mood disorders: A meta-analysis","volume":"276","author":"McIntyre","year":"2020","journal-title":"J. Affect. Disord."},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"102127","DOI":"10.1016\/j.eclinm.2023.102127","article-title":"Ketamine for the treatment of major depression: A systematic review and meta-analysis","volume":"62","author":"Nikolin","year":"2023","journal-title":"eClinicalMedicine"},{"key":"ref_214","doi-asserted-by":"crossref","unstructured":"Jiang, Y., Peng, T., Gaur, U., Silva, M., Little, P., Chen, Z., Qiu, W., Zhang, Y., and Zheng, W. (2019). Role of corticotropin releasing factor in the neuroimmune mechanisms of depression: Examination of current pharmaceutical and herbal therapies. Front. Cell. Neurosci., 13.","DOI":"10.3389\/fncel.2019.00290"},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0140-6736(22)02080-3","article-title":"Novel and emerging treatments for major depression","volume":"401","author":"Marwaha","year":"2023","journal-title":"Lancet"},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1161\/STROKEAHA.111.632943","article-title":"Ischemic cerebral damage: An appraisal of synaptic failure","volume":"43","author":"Hofmeijer","year":"2012","journal-title":"Stroke"},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1113\/JP270060","article-title":"Mechanisms underlying presynaptic Ca2+ transient and vesicular glutamate release at a CNS nerve terminal during in vitro ischaemia","volume":"593","author":"Lee","year":"2015","journal-title":"J. Physiol."},{"key":"ref_218","doi-asserted-by":"crossref","unstructured":"Molinaro, P., Cataldi, M., Cuomo, O., Viggiano, D., Pignataro, G., Sirabella, R., Secondo, A., Boscia, F., Pannaccione, A., and Scorziello, A. (2012). Genetically modified mice as a strategy to unravel the role played by the Na+\/Ca2+ exchanger in brain ischemia and in spatial learning and memory deficits. Sodium Calcium Exchange: A Growing Spectrum of Pathophysiological Implications: Proceedings of the 6th International Conference on Sodium Calcium Exchange, Springer.","DOI":"10.1007\/978-1-4614-4756-6_18"},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2174\/1570159X17666190927113021","article-title":"Nimodipine reappraised: An old drug with a future","volume":"18","author":"Carlson","year":"2020","journal-title":"Curr. Neuropharmacol."},{"key":"ref_220","doi-asserted-by":"crossref","unstructured":"Krasil\u2019nikova, I., Surin, A., Sorokina, E., Fisenko, A., Boyarkin, D., Balyasin, M., Demchenko, A., Pomytkin, I., and Pinelis, V. (2019). Insulin protects cortical neurons against glutamate excitotoxicity. Front. Neurosci., 13.","DOI":"10.3389\/fnins.2019.01027"},{"key":"ref_221","doi-asserted-by":"crossref","unstructured":"Viejo, L., Rubio-Alarc\u00f3n, M., Arribas, R.L., Moreno-Castro, M., P\u00e9rez-Mar\u00edn, R., Braun-Cornejo, M., Estrada-Valencia, M., and de Los R\u00edos, C. (2021). Synthesis and biological assessment of 4, 1-benzothiazepines with neuroprotective activity on the Ca2+ overload for the treatment of neurodegenerative diseases and stroke. Molecules, 26.","DOI":"10.3390\/molecules26154473"},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/s41598-017-18774-0","article-title":"Ischemia-induced neuronal cell death is mediated by chemokine receptor CX3CR1","volume":"8","author":"Wang","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_223","first-page":"13","article-title":"Evaluation of bioaccessibility and functional properties of kombucha beverages fortified with different medicinal plant extracts","volume":"45","author":"Tamer","year":"2021","journal-title":"Turk. J. Agric. For."},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"2718","DOI":"10.1021\/acschemneuro.1c00206","article-title":"Evolving role of natural products from traditional medicinal herbs in the treatment of Alzheimer\u2019s disease","volume":"12","author":"Pandey","year":"2021","journal-title":"ACS Chem. Neurosci."},{"key":"ref_225","first-page":"360","article-title":"The Comprehensive Review of Amlyiod Hypothesis in Alzheimer\u2019s (AD)","volume":"5","author":"Lawate","year":"2026","journal-title":"World"},{"key":"ref_226","first-page":"1","article-title":"Plants with traditional uses and activities, relevant to the management of Alzheimer\u2019s disease and other cognitive disorders","volume":"17","author":"Howes","year":"2003","journal-title":"Phytother. Res. Int. J. Devoted Pharmacol. Toxicol. Eval. Nat. Prod. Deriv."},{"key":"ref_227","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1021\/acs.est.5c10338","article-title":"Impact of Textile-Derived Micro-and Nanoplastics on Brain Health: An Emerging Environmental Risk","volume":"60","author":"Bayattork","year":"2026","journal-title":"Environ. Sci. Technol."},{"key":"ref_228","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1002\/mds.70156","article-title":"Focused Ultrasound for the Treatment of Circuit and Molecular Pathology in Parkinson\u2019s Disease","volume":"41","author":"Kofoed","year":"2026","journal-title":"Mov. Disord."},{"key":"ref_229","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2174\/138161212798918995","article-title":"Curcumin: A potential neuroprotective agent in Parkinson\u2019s disease","volume":"18","author":"Mythri","year":"2012","journal-title":"Curr. Pharm. Des."},{"key":"ref_230","doi-asserted-by":"crossref","first-page":"157943","DOI":"10.1016\/j.phymed.2026.157943","article-title":"Neuroprotective effects and mechanism of ginseng aqueous extract against Alzheimer\u2019s disease","volume":"153","author":"Zhang","year":"2026","journal-title":"Phytomedicine"},{"key":"ref_231","doi-asserted-by":"crossref","first-page":"1006134","DOI":"10.37349\/en.2026.1006134","article-title":"Redox-oxidative stress and micronutrients interplay in the clinical phenotype of schizophrenia in Nigerian subjects","volume":"5","author":"Oso","year":"2026","journal-title":"Explor. Neurosci."},{"key":"ref_232","doi-asserted-by":"crossref","first-page":"3336","DOI":"10.1038\/s41380-026-03450-5","article-title":"Neuroinflammation: An unfortunate term to describe schizophrenia","volume":"31","author":"Parellada","year":"2026","journal-title":"Mol. Psychiatry"},{"key":"ref_233","first-page":"23","article-title":"Modulation of neurotrophic signaling pathways by polyphenols","volume":"10","author":"Moosavi","year":"2015","journal-title":"Drug Des. Dev. Ther."},{"key":"ref_234","first-page":"68","article-title":"Synaptic dysfunction in depression: Potential therapeutic targets","volume":"38","author":"Rs","year":"2012","journal-title":"Science"},{"key":"ref_235","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/s41572-023-00454-1","article-title":"Major depressive disorder","volume":"9","author":"Marx","year":"2023","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_236","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.jad.2014.06.001","article-title":"Curcumin for the treatment of major depression: A randomised, double-blind, placebo controlled study","volume":"167","author":"Lopresti","year":"2014","journal-title":"J. Affect. Disord."},{"key":"ref_237","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jacc.2025.11.008","article-title":"Vascular Cognitive Impairment and Dementia: Clinical Features, Neuropathology, and Biomarkers","volume":"87","author":"Sachdev","year":"2026","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_238","doi-asserted-by":"crossref","first-page":"8","DOI":"10.5142\/jgr.2013.37.8","article-title":"A comprehensive review of the therapeutic and pharmacological effects of ginseng and ginsenosides in central nervous system","volume":"37","author":"Kim","year":"2013","journal-title":"J. Ginseng Res."},{"key":"ref_239","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1039\/b800422f","article-title":"The impact of flavonoids on memory: Physiological and molecular considerations","volume":"38","author":"Spencer","year":"2009","journal-title":"Chem. Soc. Rev."},{"key":"ref_240","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.jalz.2010.01.013","article-title":"Beneficial effects of docosahexaenoic acid on cognition in age-related cognitive decline","volume":"6","author":"McCarthy","year":"2010","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_241","first-page":"219","article-title":"An examination of the efficacy of Ginkgo biloba extract EGb 761 on the neuropsychologic functioning of cognitively intact older adults","volume":"6","author":"Mix","year":"2000","journal-title":"J. Altern. Complement. Med. Paradig. Pract. Policy Adv. Integr. Health"},{"key":"ref_242","doi-asserted-by":"crossref","first-page":"e82891","DOI":"10.2196\/82891","article-title":"Efficacy of Bacopa monnieri (Linn.) on Cognitive Function and Alterations in Blood Metabolites in Patients with Amnestic Mild Cognitive Impairment and Early Alzheimer Disease: Protocol for an Exploratory Double-Blind, Randomized, Placebo-Controlled Trial","volume":"15","author":"Dwivedi","year":"2026","journal-title":"JMIR Res. Protoc."},{"key":"ref_243","doi-asserted-by":"crossref","unstructured":"Salari, N., Lotfi, F., Abdolmaleki, A., Heidarian, P., Rasoulpoor, S., Fazeli, J., Najafi, H., and Mohammadi, M. (2025). The global prevalence of mild cognitive impairment in geriatric population with emphasis on influential factors: A systematic review and meta-analysis. BMC Geriatr., 25.","DOI":"10.1186\/s12877-025-05967-w"},{"key":"ref_244","doi-asserted-by":"crossref","unstructured":"Gregory, J., Vengalasetti, Y.V., Bredesen, D.E., and Rao, R.V. (2021). Neuroprotective herbs for the management of Alzheimer\u2019s disease. Biomolecules, 11.","DOI":"10.3390\/biom11040543"},{"key":"ref_245","doi-asserted-by":"crossref","first-page":"5668","DOI":"10.1002\/ptr.7203","article-title":"Bacosides from Bacopa monnieri extract: An overview of the effects on neurological disorders","volume":"35","author":"Banerjee","year":"2021","journal-title":"Phytother. Res."},{"key":"ref_246","doi-asserted-by":"crossref","first-page":"113626","DOI":"10.1016\/j.indcrop.2021.113626","article-title":"Statistical optimization of in vitro callus induction of wild and cultivated varieties of Mucuna pruriens L. (DC.) using response surface methodology and assessment of L-Dopa biosynthesis","volume":"169","author":"Tandon","year":"2021","journal-title":"Ind. Crops Prod."},{"key":"ref_247","doi-asserted-by":"crossref","unstructured":"Anand, U., Jacobo-Herrera, N., Altemimi, A., and Lakhssassi, N. (2019). A comprehensive review on medicinal plants as antimicrobial therapeutics: Potential avenues of biocompatible drug discovery. Metabolites, 9.","DOI":"10.3390\/metabo9110258"},{"key":"ref_248","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1007\/s40265-022-01701-7","article-title":"Benefits and harms of \u2018smart drugs\u2019 (nootropics) in healthy individuals","volume":"82","author":"Schifano","year":"2022","journal-title":"Drugs"},{"key":"ref_249","unstructured":"Greenfield, B. (2020). Boundless: Upgrade Your Brain, Optimize Your Body & Defy Aging, Victory Belt Publishing."},{"key":"ref_250","doi-asserted-by":"crossref","first-page":"4391375","DOI":"10.1155\/2016\/4391375","article-title":"Establishing natural nootropics: Recent molecular enhancement influenced by natural nootropic","volume":"2016","author":"Suliman","year":"2016","journal-title":"Evid.-Based Complement. Altern. Med."},{"key":"ref_251","doi-asserted-by":"crossref","unstructured":"Manetti, D., Dei, S., Arias, H.R., Braconi, L., Gabellini, A., Teodori, E., and Romanelli, M.N. (2023). Recent advances in the discovery of nicotinic acetylcholine receptor allosteric modulators. Molecules, 28.","DOI":"10.3390\/molecules28031270"},{"key":"ref_252","doi-asserted-by":"crossref","unstructured":"Phogat, J., Bali, A., and Kapoor, N. (2023). Smart Drugs in Cognitive Disorders. Applications of Synthetic Biology in Health, Energy, and Environment, IGI Global Scientific Publishing.","DOI":"10.4018\/978-1-6684-6577-6.ch010"},{"key":"ref_253","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2174\/1570159X11311030006","article-title":"Acetylcholinesterase inhibitors: Pharmacology and toxicology","volume":"11","author":"Colovic","year":"2013","journal-title":"Curr. Neuropharmacol."},{"key":"ref_254","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S0007114515001452","article-title":"The role of dietary coconut for the prevention and treatment of Alzheimer\u2019s disease: Potential mechanisms of action","volume":"114","author":"Fernando","year":"2015","journal-title":"Br. J. Nutr."},{"key":"ref_255","doi-asserted-by":"crossref","unstructured":"Molz, P., and Schr\u00f6der, N. (2017). Potential therapeutic effects of lipoic acid on memory deficits related to aging and neurodegeneration. Front. Pharmacol., 8.","DOI":"10.3389\/fphar.2017.00849"},{"key":"ref_256","doi-asserted-by":"crossref","unstructured":"Srivastava, A., Srivastava, P., Pandey, A., Khanna, V., and Pant, A. (2019). Phytomedicine: A potential alternative medicine in controlling neurological disorders. New Look to Phytomedicine, Elsevier.","DOI":"10.1016\/B978-0-12-814619-4.00025-2"},{"key":"ref_257","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1080\/1028415X.2001.11747370","article-title":"Dose dependent changes in cognitive performance and mood following acute administration of Ginseng to healthy young volunteers","volume":"4","author":"Kennedy","year":"2001","journal-title":"Nutr. Neurosci."},{"key":"ref_258","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1080\/1028415X.2001.11747376","article-title":"Differential, dose dependent changes in cognitive performance following acute administration of a Ginkgo biloba\/Panax ginseng combination to healthy young volunteers","volume":"4","author":"Kennedy","year":"2001","journal-title":"Nutr. Neurosci."},{"key":"ref_259","doi-asserted-by":"crossref","first-page":"112769","DOI":"10.1016\/j.jep.2020.112769","article-title":"Neurodegenerative diseases and Withania somnifera (L.): An update","volume":"256","author":"Dar","year":"2020","journal-title":"J. Ethnopharmacol."},{"key":"ref_260","doi-asserted-by":"crossref","unstructured":"Baddaoui, S., Saalaoui, E., Khibech, O., Salagre, D., Fern\u00e1ndez-Ochoa, \u00c1., Mamri, S., Aktary, N., Rahman, M., Rani, A., and Asehraou, A. (2026). HPLC-ESI-QTOF-MS\/MS-Guided Profiling of Bioactive Compounds in Fresh and Stored Saffron Corms Reveals Potent Anticancer Activity Against Colorectal Cancer. Pharmaceuticals, 19.","DOI":"10.3390\/ph19010149"},{"key":"ref_261","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1007\/s12272-023-01484-9","article-title":"Herbal medicine and gut microbiota: Exploring untapped therapeutic potential in neurodegenerative disease management","volume":"47","author":"Guan","year":"2024","journal-title":"Arch. Pharmacal Res."},{"key":"ref_262","doi-asserted-by":"crossref","unstructured":"Zheng, S.-Y., and Zhou, X.-Q. (2025). A perspective on the mechanisms of herbal medicine for cognitive impairment. Front. Neurol., 16.","DOI":"10.3389\/fneur.2025.1610542"},{"key":"ref_263","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.2174\/011570159X353541250128101649","article-title":"Restoring Gut-brain Function by Medicinal Herbs Offering Neuroprotection through Suppressing Inflammatory Pathways: A Systematic Review","volume":"23","author":"Abbaszadeh","year":"2025","journal-title":"Curr. Neuropharmacol."},{"key":"ref_264","doi-asserted-by":"crossref","first-page":"240","DOI":"10.17305\/bb.2025.12921","article-title":"Gut microbial metabolites and the brain\u2013gut axis in Alzheimer\u2019s disease: A review","volume":"26","author":"Ji","year":"2025","journal-title":"Biomol. Biomed."},{"key":"ref_265","doi-asserted-by":"crossref","unstructured":"Koga-Batko, J., Antosz-Popio\u0142ek, K., Suchecki, W., Szyller, H., Wrze\u015bniewska, M., Dyda, M., and Leszek, J. (2025). Influence of the Gut Microbiota on the Pathogenesis of Alzheimer\u2019s Disease: A Literature Review. Cells, 14.","DOI":"10.3390\/cells14201578"},{"key":"ref_266","doi-asserted-by":"crossref","first-page":"107838","DOI":"10.1016\/j.micpath.2025.107838","article-title":"Nonthermal plasma jet mitigates viral replication and inflammation in human coronavirus 229E-infected lung cells by targeting the NF-\u03baB and MAPK pathways","volume":"206","author":"Akter","year":"2025","journal-title":"Microb. Pathog."},{"key":"ref_267","doi-asserted-by":"crossref","unstructured":"Tkaczenko, H., Buyun, L., Ko\u0142odziejska, R., Kami\u0144ski, P., and Kurhaluk, N. (2025). Neuroactive phytochemicals as multi-target modulators of mental health and cognitive function: An integrative review. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26188907"},{"key":"ref_268","doi-asserted-by":"crossref","unstructured":"Meng, W., Chao, W., Kaiwei, Z., Sijia, M., Jiajia, S., and Shijie, X. (2025). Bioactive compounds from Chinese herbal plants for neurological health: Mechanisms, pathways, and functional food applications. Front. Nutr., 12.","DOI":"10.3389\/fnut.2025.1537363"},{"key":"ref_269","doi-asserted-by":"crossref","first-page":"9348046","DOI":"10.1155\/2018\/9348046","article-title":"Herbal compounds play a role in neuroprotection through the inhibition of microglial activation","volume":"2018","author":"Fu","year":"2018","journal-title":"J. Immunol. Res."},{"key":"ref_270","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s43556-025-00307-1","article-title":"Microbiota\u2013gut\u2013brain axis in neurodegenerative diseases: Molecular mechanisms and therapeutic targets","volume":"6","author":"Chen","year":"2025","journal-title":"Mol. Biomed."},{"key":"ref_271","unstructured":"Koike, A., and Takagi, T. (2004, January 6). Gene\/protein\/family name recognition in biomedical literature. Proceedings of the HLT-NAACL 2004 Workshop: Linking Biological Literature, Ontologies and Databases, Boston, MA, USA."},{"key":"ref_272","doi-asserted-by":"crossref","unstructured":"Odia, A., and Esezobor, O.Z. (2017). Therapeutic uses of amino acids. Amino Acid\u2014New Insights and Roles in Plant and Animal, IntechOpen.","DOI":"10.5772\/intechopen.68932"},{"key":"ref_273","doi-asserted-by":"crossref","unstructured":"Bukke, V.N., Villani, R., Archana, M., Wawrzyniak, A., Balawender, K., Orkisz, S., Ferraro, L., Serviddio, G., and Cassano, T. (2020). The glucose metabolic pathway as a potential target for therapeutics: Crucial role of glycosylation in Alzheimer\u2019s disease. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21207739"},{"key":"ref_274","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.4155\/fmc.09.121","article-title":"Synthetic and natural iron chelators: Therapeutic potential and clinical use","volume":"1","author":"Hatcher","year":"2009","journal-title":"Future Med. Chem."},{"key":"ref_275","doi-asserted-by":"crossref","unstructured":"Yan, N., and Zhang, J. (2020). Iron metabolism, ferroptosis, and the links with Alzheimer\u2019s disease. Front. Neurosci., 13.","DOI":"10.3389\/fnins.2019.01443"},{"key":"ref_276","doi-asserted-by":"crossref","first-page":"e30946","DOI":"10.1016\/j.heliyon.2024.e30946","article-title":"Docosahexaenoic acid-loaded nanoparticles: A state-of-the-art of preparation methods, characterization, functionality, and therapeutic applications","volume":"10","author":"Ali","year":"2024","journal-title":"Heliyon"},{"key":"ref_277","doi-asserted-by":"crossref","unstructured":"Rai, S.N., Singh, P., Steinbusch, H.W., Vamanu, E., Ashraf, G., and Singh, M.P. (2021). The role of vitamins in neurodegenerative disease: An update. Biomedicines, 9.","DOI":"10.3390\/biomedicines9101284"},{"key":"ref_278","doi-asserted-by":"crossref","first-page":"545","DOI":"10.2174\/1871527322666230526164421","article-title":"Is There a Role of Vitamin D in Alzheimer\u2019s disease?","volume":"23","author":"Plantone","year":"2024","journal-title":"CNS Neurol. Disord.-Drug Targets"},{"key":"ref_279","doi-asserted-by":"crossref","first-page":"171166","DOI":"10.1016\/j.peptides.2024.171166","article-title":"Therapeutic potential of vasopressin in the treatment of neurological disorders","volume":"174","author":"Mishra","year":"2024","journal-title":"Peptides"},{"key":"ref_280","doi-asserted-by":"crossref","first-page":"49","DOI":"10.31083\/j.jin2303049","article-title":"Neuromodulation of Cardiac Ischemic Pain: Role of the Autonomic Nervous System and Vasopressin","volume":"23","year":"2024","journal-title":"J. Integr. Neurosci."},{"key":"ref_281","doi-asserted-by":"crossref","unstructured":"Harborne, J. (1989). Flavonoids. Natural Products of Woody Plants: Chemicals Extraneous to the Lignocellulosic Cell Wall, Springer.","DOI":"10.1007\/978-3-642-74075-6_16"},{"key":"ref_282","doi-asserted-by":"crossref","unstructured":"Mattioli, R., Francioso, A., Mosca, L., and Silva, P. (2020). Anthocyanins: A comprehensive review of their chemical properties and health effects on cardiovascular and neurodegenerative diseases. Molecules, 25.","DOI":"10.3390\/molecules25173809"},{"key":"ref_283","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.cofs.2019.03.008","article-title":"Current evidence on cognitive improvement and neuroprotection promoted by anthocyanins","volume":"26","author":"Batista","year":"2019","journal-title":"Curr. Opin. Food Sci."},{"key":"ref_284","doi-asserted-by":"crossref","unstructured":"Zahi, A., Rani, A., Aktary, N., Rahman, M., Mekhfi, H., Ziyyat, A., Park, M.N., Legssyer, A., and Kim, B. (2025). Cardiovascular Effects, Phytochemistry, Drug Interactions, and Safety Profile of Foeniculum vulgare Mill. (Fennel): A Comprehensive Review. Pharmaceuticals, 18.","DOI":"10.3390\/ph18111761"},{"key":"ref_285","doi-asserted-by":"crossref","first-page":"27657","DOI":"10.1039\/D4RA04730C","article-title":"FDA-approved drugs containing dimethylamine pharmacophore: A review of the last 50 years","volume":"14","author":"Bindra","year":"2024","journal-title":"RSC Adv."},{"key":"ref_286","doi-asserted-by":"crossref","first-page":"100836","DOI":"10.1016\/j.bbih.2024.100836","article-title":"Maternal choline supplementation modulates cognition and induces anti-inflammatory signaling in the prefrontal cortices of adolescent rats exposed to maternal immune activation","volume":"40","author":"King","year":"2024","journal-title":"Brain Behav. Immun.-Health"},{"key":"ref_287","doi-asserted-by":"crossref","unstructured":"Cadon\u00e1, F.C., Weis, G.C.C., Assmann, C.E., de Oliveira Alves, A., Bonadiman, B.d.S.R., Machado, A.K., Montano, M.A.E., and da Cruz, I.B.M. (2019). Functional and medicinal properties of caffeine-based common beverages. Caffeinated and Cocoa Based Beverages, Elsevier.","DOI":"10.1016\/B978-0-12-815864-7.00001-5"},{"key":"ref_288","doi-asserted-by":"crossref","first-page":"2","DOI":"10.12688\/healthopenres.13504.1","article-title":"Understanding nootropics and cognitive enhancement: Mechanism of action and ethical considerations","volume":"6","author":"Patel","year":"2024","journal-title":"Health Open Res."},{"key":"ref_289","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.1007\/s12035-023-03793-y","article-title":"Phospholipidomics in clinical trials for brain disorders: Advancing our understanding and therapeutic potentials","volume":"61","author":"Hachem","year":"2024","journal-title":"Mol. Neurobiol."},{"key":"ref_290","doi-asserted-by":"crossref","first-page":"3928","DOI":"10.1080\/10408398.2024.2377290","article-title":"Revisiting the role of phospholipases in alzheimer\u2019s: Crosstalk with processed food","volume":"65","author":"Pethe","year":"2024","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"ref_291","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1515\/JBCPP.2010.21.1.93","article-title":"Therapeutic potential of Phyllanthus emblica (amla): The ayurvedic wonder","volume":"21","author":"Mirunalini","year":"2010","journal-title":"J. Basic Clin. Physiol. Pharmacol."},{"key":"ref_292","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1007\/s11011-019-00400-9","article-title":"Exploring the multifaceted neuroprotective actions of Emblica officinalis (Amla): A review","volume":"34","author":"Husain","year":"2019","journal-title":"Metab. Brain Dis."},{"key":"ref_293","unstructured":"Mishra, S., Yadav, A., and Rajan, N. (2021). Medicinal uses of Brahmi. Traditional Utilization and Pharmacological Properties of Medicinal Plants, Scripown Publications."},{"key":"ref_294","doi-asserted-by":"crossref","first-page":"108153","DOI":"10.1016\/j.abb.2019.108153","article-title":"Brahmi (Bacopa monnieri): An ayurvedic herb against the Alzheimer\u2019s disease","volume":"676","author":"Dubey","year":"2019","journal-title":"Arch. Biochem. Biophys."},{"key":"ref_295","first-page":"5","article-title":"Pharmacological and clinical properties of curcumin","volume":"2011","author":"Beevers","year":"2011","journal-title":"Bot. Targets Ther."},{"key":"ref_296","doi-asserted-by":"crossref","first-page":"105790","DOI":"10.1016\/j.neuint.2024.105790","article-title":"Curcumin as a potential therapeutic agent for treating neurodegenerative diseases","volume":"178","author":"Purushotham","year":"2024","journal-title":"Neurochem. Int."},{"key":"ref_297","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1007\/s10787-024-01492-1","article-title":"The regulating effect of curcumin on NF-\u03baB pathway in neurodegenerative diseases: A review of the underlying mechanisms","volume":"32","author":"Esmaealzadeh","year":"2024","journal-title":"Inflammopharmacology"},{"key":"ref_298","doi-asserted-by":"crossref","unstructured":"Rahman, M., Akter, K., Ahmed, K.R., Fahim, M.M.H., Aktary, N., Park, M.N., Shin, S.-W., and Kim, B. (2024). Synergistic Strategies for Castration-Resistant Prostate Cancer: Targeting AR-V7, Exploring Natural Compounds, and Optimizing FDA-Approved Therapies. Cancers, 16.","DOI":"10.3390\/cancers16162777"},{"key":"ref_299","doi-asserted-by":"crossref","unstructured":"Akter, K., Gul, K., and Mumtaz, S. (2025). Revisiting Curcumin in cancer therapy: Recent insights into molecular Mechanisms, Nanoformulations, and synergistic combinations. Curr. Issues Mol. Biol., 47.","DOI":"10.3390\/cimb47090716"},{"key":"ref_300","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1142\/S0192415X24500435","article-title":"Comprehensive exploration of the neuroprotective mechanisms of Ginkgo biloba leaves in treating neurological disorders","volume":"52","author":"Liu","year":"2024","journal-title":"Am. J. Chin. Med."},{"key":"ref_301","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.fitote.2008.05.007","article-title":"Biology and chemistry of Ginkgo biloba","volume":"79","author":"Singh","year":"2008","journal-title":"Fitoterapia"},{"key":"ref_302","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.jgr.2023.03.001","article-title":"Panax ginseng in the treatment of Alzheimer\u2019s disease and vascular dementia","volume":"47","author":"Wang","year":"2023","journal-title":"J. Ginseng Res."},{"key":"ref_303","doi-asserted-by":"crossref","first-page":"9","DOI":"10.9734\/jpri\/2021\/v33i29B31584","article-title":"Therapeutic role of ginger (Zingiber officinale)\u2014A review","volume":"33","author":"Kausar","year":"2021","journal-title":"J. Pharm. Res. Int."},{"key":"ref_304","doi-asserted-by":"crossref","first-page":"14114","DOI":"10.53730\/ijhs.v6nS1.8576","article-title":"A Review on Memory Enhancing Activity of Ginger","volume":"6","author":"Chnadrashekhar","year":"2022","journal-title":"Int. J. Health Sci."},{"key":"ref_305","doi-asserted-by":"crossref","unstructured":"Arcusa, R., Villa\u00f1o, D., Marhuenda, J., Cano, M., Cerd\u00e0, B., and Zafrilla, P. (2022). Potential role of ginger (Zingiber officinale Roscoe) in the prevention of neurodegenerative diseases. Front. Nutr., 9.","DOI":"10.3389\/fnut.2022.809621"},{"key":"ref_306","doi-asserted-by":"crossref","unstructured":"Sun, B., Wu, L., Wu, Y., Zhang, C., Qin, L., Hayashi, M., Kudo, M., Gao, M., and Liu, T. (2020). Therapeutic potential of Centella asiatica and its triterpenes: A review. Front. Pharmacol., 11.","DOI":"10.3389\/fphar.2020.568032"},{"key":"ref_307","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.3233\/JAD-210271","article-title":"Prolonged treatment with Centella asiatica improves memory, reduces amyloid-\u03b2 pathology, and activates NRF2-regulated antioxidant response pathway in 5xFAD Mice","volume":"81","author":"Zweig","year":"2021","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_308","doi-asserted-by":"crossref","unstructured":"Thakurdesai, P.A. (2021). Centella asiatica (Gotu kola) leaves: Potential in neuropsychiatric conditions. Nutraceuticals in Brain Health and Beyond, Elsevier.","DOI":"10.1016\/B978-0-12-820593-8.00021-5"},{"key":"ref_309","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s11011-023-01294-4","article-title":"Therapeutic potentialities of green tea (Camellia sinensis) in ischemic stroke: Biochemical and molecular evidence","volume":"39","author":"Azami","year":"2024","journal-title":"Metab. Brain Dis."},{"key":"ref_310","doi-asserted-by":"crossref","unstructured":"Pandit, N., Kulkarni, S., and Singhvi, G. (2024). Effect of green tea on human brain health. Nutraceutical Fruits and Foods for Neurodegenerative Disorders, Elsevier.","DOI":"10.1016\/B978-0-443-18951-7.00018-9"},{"key":"ref_311","first-page":"1","article-title":"Guduchi (Tinospora cordifolia): Biological and Medicinal properties, a review","volume":"6","author":"Krishna","year":"2009","journal-title":"Internet J. Altern. Med."},{"key":"ref_312","doi-asserted-by":"crossref","first-page":"100775","DOI":"10.1016\/j.hermed.2023.100775","article-title":"Tinospora cordifolia: A potential neuroprotective agent against various neurodegenerative diseases","volume":"42","author":"Singh","year":"2023","journal-title":"J. Herb. Med."},{"key":"ref_313","doi-asserted-by":"crossref","first-page":"151","DOI":"10.4103\/0257-7941.107344","article-title":"Tinospora cordifolia: One plant, many roles","volume":"31","author":"Saha","year":"2012","journal-title":"Anc. Sci. Life"},{"key":"ref_314","doi-asserted-by":"crossref","unstructured":"Al Housseini, I., Dakdouk, H., El Natour, H., and Borjac, J. (2026). Dual Neuroprotective and Nephroprotective Effects of Mucuna pruriens, Moringa oleifera, and Silybum marianum (Milk Thistle) via Modulation of PI3K\/AKT\/mTOR and Nrf2\/NF-\u03baB Pathways in a Murine Comorbid PD\u2013AKI Model. Int. J. Mol. Sci., 27.","DOI":"10.3390\/ijms27094021"},{"key":"ref_315","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1016\/j.fct.2008.04.018","article-title":"Moringa oleifera Lam prevents acetaminophen induced liver injury through restoration of glutathione level","volume":"46","author":"Fakurazi","year":"2008","journal-title":"Food Chem. Toxicol."},{"key":"ref_316","doi-asserted-by":"crossref","unstructured":"Aljadaan, A.M., AlSaadi, A.M., Shaikh, I.A., Whitby, A., Ray, A., Kim, D.-H., and Carter, W.G. (2025). Characterization of the Anticholinesterase and Antioxidant Properties of Phytochemicals from Moringa oleifera as a Potential Treatment for Alzheimer\u2019s Disease. Biomedicines, 13.","DOI":"10.3390\/biomedicines13092148"},{"key":"ref_317","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.pharmthera.2011.01.010","article-title":"Therapeutic applications of compounds in the Magnolia family","volume":"130","author":"Lee","year":"2011","journal-title":"Pharmacol. Ther."},{"key":"ref_318","doi-asserted-by":"crossref","unstructured":"Zhu, S., Liu, F., Zhang, R., Xiong, Z., Zhang, Q., Hao, L., and Chen, S. (2022). Neuroprotective potency of neolignans in Magnolia officinalis cortex against brain disorders. Front. Pharmacol., 13.","DOI":"10.3389\/fphar.2022.857449"},{"key":"ref_319","doi-asserted-by":"crossref","first-page":"e17186","DOI":"10.1097\/MD.0000000000017186","article-title":"An investigation into the stress-relieving and pharmacological actions of an ashwagandha (Withania somnifera) extract: A randomized, double-blind, placebo-controlled study","volume":"98","author":"Lopresti","year":"2019","journal-title":"Medicine"},{"key":"ref_320","doi-asserted-by":"crossref","unstructured":"Kumar, P. (2026). Neurotherapeutic Potential of Withania somnifera: Insights from Ayurvedic Medicine. Ashwagandha, CRC Press.","DOI":"10.1201\/9781032675961-24"},{"key":"ref_321","doi-asserted-by":"crossref","first-page":"100434","DOI":"10.1016\/j.hermed.2021.100434","article-title":"Ashwagandha (Withania somnifera) for the treatment and enhancement of mental and physical conditions: A systematic review of human trials","volume":"28","author":"Lopresti","year":"2021","journal-title":"J. Herb. Med."},{"key":"ref_322","doi-asserted-by":"crossref","unstructured":"P\u00e9rez-G\u00f3mez, J., Villafaina, S., Adsuar, J.C., Merellano-Navarro, E., and Collado-Mateo, D. (2020). Effects of Ashwagandha (Withania somnifera) on VO2max: A systematic review and meta-analysis. Nutrients, 12.","DOI":"10.3390\/nu12041119"},{"key":"ref_323","doi-asserted-by":"crossref","unstructured":"Pradeep, H.L.N.R., Perera, P.K., Waratenne, P.R., Samaranayake, N., and Dissanayake, W.D.N. (2026). Effects of Bacopa monnieri herbal supplement on aging and neurocognitive functions, including neurophysiological assessments, in relation to constitution (Prakriti) in healthy adults: Clinical trial protocol. Front. Med., 13.","DOI":"10.3389\/fmed.2026.1702773"},{"key":"ref_324","doi-asserted-by":"crossref","unstructured":"Feng, J.-X., Zheng, M.-Q., Tian, X., Zimmermann, A., Wang, A.-X., and Meng, X. (2025). Ginkgo biloba extract EGb 761 in patients with dementia and a history of cerebral infarction\u2014Meta-analysis of pooled data from randomised clinical trials. Front. Neurol., 16.","DOI":"10.3389\/fneur.2025.1658064"},{"key":"ref_325","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1080\/15622975.2024.2446830","article-title":"Ginkgo biloba extract EGb 761 is safe and effective in the treatment of mild dementia\u2013a meta-analysis of patient subgroups in randomised controlled trials","volume":"26","author":"Riepe","year":"2025","journal-title":"World J. Biol. Psychiatry"},{"key":"ref_326","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1089\/acm.2016.0379","article-title":"Spearmint extract improves working memory in men and women with age-associated memory impairment","volume":"24","author":"Herrlinger","year":"2018","journal-title":"J. Altern. Complement. Med."},{"key":"ref_327","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1111\/bph.14898","article-title":"Role of phytochemicals as nutraceuticals for cognitive functions affected in ageing","volume":"177","author":"Howes","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"ref_328","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s11418-020-01451-4","article-title":"Diosgenin content is a novel criterion to assess memory enhancement effect of yam extracts","volume":"75","author":"Yang","year":"2021","journal-title":"J. Nat. Med."},{"key":"ref_329","doi-asserted-by":"crossref","first-page":"100613","DOI":"10.1016\/j.phyplu.2024.100613","article-title":"Diosgenin-rich Yam (rhizome of Dioscorea batatas) extract ameliorates cognitive functions and plasma biomarkers for mild cognitive impairment and mild Alzheimer\u2019s disease: A randomized controlled trial","volume":"4","author":"Inada","year":"2024","journal-title":"Phytomed. Plus"},{"key":"ref_330","doi-asserted-by":"crossref","first-page":"078881","DOI":"10.1136\/bmj-2023-078881","article-title":"Advances in the drug treatment of Alzheimer\u2019s disease: Pathophysiology and mechanisms of action","volume":"393","author":"Nowell","year":"2026","journal-title":"BMJ"},{"key":"ref_331","doi-asserted-by":"crossref","unstructured":"Reiss, A.B., Gulkarov, S., Jacob, B., Srivastava, A., Pinkhasov, A., Gomolin, I.H., Stecker, M.M., Wisniewski, T., and De Leon, J. (2024). Mitochondria in Alzheimer\u2019s disease pathogenesis. Life, 14.","DOI":"10.3390\/life14020196"},{"key":"ref_332","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.4103\/NRR.NRR-D-25-00144","article-title":"Metabolic breakdown: Linking insulin resistance and mitochondrial dysfunction to neurodegeneration in Alzheimer\u2019s disease","volume":"21","author":"Lanzillotta","year":"2026","journal-title":"Neural Regen. Res."},{"key":"ref_333","doi-asserted-by":"crossref","first-page":"e70657","DOI":"10.1111\/cns.70657","article-title":"AMPK\/SIRT1\/PGC-1\u03b1 Signaling Pathway: Molecular Mechanisms and Targeted Strategies From Energy Homeostasis Regulation to Disease Therapy","volume":"31","author":"Chen","year":"2025","journal-title":"CNS Neurosci. Ther."},{"key":"ref_334","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.neuron.2014.12.007","article-title":"The roles of PINK1, parkin, and mitochondrial fidelity in Parkinson\u2019s disease","volume":"85","author":"Pickrell","year":"2015","journal-title":"Neuron"},{"key":"ref_335","doi-asserted-by":"crossref","first-page":"e1056332","DOI":"10.1080\/23723556.2015.1056332","article-title":"Mitophagy: In sickness and in health","volume":"3","author":"Palikaras","year":"2016","journal-title":"Mol. Cell. Oncol."},{"key":"ref_336","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.cmet.2012.04.003","article-title":"SIRT1 is required for AMPK activation and the beneficial effects of resveratrol on mitochondrial function","volume":"15","author":"Price","year":"2012","journal-title":"Cell Metab."},{"key":"ref_337","doi-asserted-by":"crossref","first-page":"e70369","DOI":"10.1002\/jbt.70369","article-title":"Neuroprotective potential of curcumin in neurodegenerative diseases: Clinical insights into cellular and molecular signaling pathways","volume":"39","author":"Islam","year":"2025","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"ref_338","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s11090-025-10632-6","article-title":"Investigating the Synergistic Effect of Nitric Oxide Plasma-treated Water and Curcumin on Apoptosis in Lung Cancer Cells via intrinsic and ATR\/ATM\/p53-Dependent Pathways: An In Vitro Study","volume":"46","author":"Akter","year":"2026","journal-title":"Plasma Chem. Plasma Process."},{"key":"ref_339","doi-asserted-by":"crossref","unstructured":"Ahn, C.-H., Myong, J.S., Ahmed, K.R., Rahman, M.A., Fahim, M.M.H., Choi, M., Rahman, M., Choi, J., Kim, K., and Moon, S. (2025). A pharmacoinformatic approach for studying Atractylodes Lancea DC\u2019s anticancer potential and control ROS-mediated apoptosis against prostate cancer cells. Front. Oncol., 15.","DOI":"10.3389\/fonc.2025.1471110"},{"key":"ref_340","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.56499\/jppres_14.1.2274","article-title":"Use of curcumin as a potential therapeutic agent in Alzheimer\u2019s disease: A systematic review","volume":"14","year":"2026","journal-title":"J. Pharm. Pharmacogn. Res."},{"key":"ref_341","doi-asserted-by":"crossref","first-page":"112775","DOI":"10.1016\/j.mce.2026.112775","article-title":"Effects and mechanisms of ginsenoside Rg1 in alleviating hypothalamic oxidative stress and metabolic dysfunction via Nrf2-Tyrosine metabolism axis","volume":"616","author":"Huang","year":"2026","journal-title":"Mol. Cell. Endocrinol."},{"key":"ref_342","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s12035-025-05513-0","article-title":"miR-132 and Its Exosomal Form in Alzheimer\u2019s Disease: Linking Epigenetic Regulation to Neurodegeneration","volume":"63","author":"Oriquat","year":"2026","journal-title":"Mol. Neurobiol."},{"key":"ref_343","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.neuroscience.2019.08.020","article-title":"Histone deacetylase inhibitor MS-275 alleviates postoperative cognitive dysfunction in rats by inhibiting hippocampal neuroinflammation","volume":"417","author":"Wu","year":"2019","journal-title":"Neuroscience"},{"key":"ref_344","doi-asserted-by":"crossref","unstructured":"Ma, Y., Wang, W., Liu, S., Qiao, X., Xing, Y., Zhou, Q., and Zhang, Z. (2023). Epigenetic regulation of neuroinflammation in Alzheimer\u2019s disease. Cells, 13.","DOI":"10.3390\/cells13010079"},{"key":"ref_345","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1007\/s12035-016-0357-6","article-title":"Epigenetics in Alzheimer\u2019s disease: Perspective of DNA methylation","volume":"55","author":"Qazi","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"ref_346","doi-asserted-by":"crossref","unstructured":"Zingale, V.D., Gugliandolo, A., and Mazzon, E. (2021). MiR-155: An important regulator of neuroinflammation. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23010090"},{"key":"ref_347","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/s12035-026-05889-7","article-title":"Delivery of miR-25802 via Small Vesicles Protects Against Mitochondrial Injury, Oxidative Stress, and Neuroinflammation in Alzheimer\u2019s Disease","volume":"63","author":"Topal","year":"2026","journal-title":"Mol. Neurobiol."},{"key":"ref_348","doi-asserted-by":"crossref","first-page":"8430","DOI":"10.1038\/s41598-021-87225-8","article-title":"Curcumin activates Nrf2 through PKC\u03b4-mediated p62 phosphorylation at Ser351","volume":"11","author":"Park","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_349","doi-asserted-by":"crossref","first-page":"4384","DOI":"10.1007\/s12035-022-02859-7","article-title":"Resveratrol and neuroprotection: An insight into prospective therapeutic approaches against Alzheimer\u2019s disease from bench to bedside","volume":"59","author":"Islam","year":"2022","journal-title":"Mol. Neurobiol."},{"key":"ref_350","doi-asserted-by":"crossref","unstructured":"Merlo, S., Lipari, C.L.R., Patti, A., and Sortino, M.A. (2026). Microglial Activation Under Hypoxic Conditions in Early Alzheimer\u2019s Disease: Can Natural SIRT1 Activators Be Therapeutic Allies in the Inflammation\u2013Energy Axis?. Phytother. Res., online ahead of print.","DOI":"10.1002\/ptr.70317"},{"key":"ref_351","doi-asserted-by":"crossref","unstructured":"Yang, X., Zhou, P., Zhao, Z., Li, J., Fan, Z., Li, X., Cui, Z., and Fu, A. (2023). Improvement effect of mitotherapy on the cognitive ability of Alzheimer\u2019s disease through NAD+\/SIRT1-mediated autophagy. Antioxidants, 12.","DOI":"10.3390\/antiox12112006"},{"key":"ref_352","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s00109-022-02187-2","article-title":"Deciphering therapeutic options for neurodegenerative diseases: Insights from SIRT1","volume":"100","author":"Wang","year":"2022","journal-title":"J. Mol. Med."},{"key":"ref_353","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s11658-024-00595-5","article-title":"Impaired synaptic plasticity and decreased glutamatergic neuron excitability induced by SIRT1\/BDNF downregulation in the hippocampal CA1 region are involved in postoperative cognitive dysfunction","volume":"29","author":"Wu","year":"2024","journal-title":"Cell. Mol. Biol. Lett."},{"key":"ref_354","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.14336\/AD.2021.1215","article-title":"Mechanisms of short-chain fatty acids derived from gut microbiota in Alzheimer\u2019s disease","volume":"13","author":"Qian","year":"2022","journal-title":"Aging Dis."},{"key":"ref_355","doi-asserted-by":"crossref","first-page":"e21888","DOI":"10.1096\/fj.202100702R","article-title":"Tryptophan-derived serotonin-kynurenine balance in immune activation and intestinal inflammation","volume":"35","author":"Haq","year":"2021","journal-title":"FASEB J."},{"key":"ref_356","doi-asserted-by":"crossref","first-page":"bvz039","DOI":"10.1210\/jendso\/bvz039","article-title":"Intestinal barrier dysfunction, LPS translocation, and disease development","volume":"4","author":"Ghosh","year":"2020","journal-title":"J. Endocr. Soc."},{"key":"ref_357","doi-asserted-by":"crossref","unstructured":"Koemel, N.A., Senior, A.M., Celermajer, D.S., Grech, A., Gill, T.P., Simpson, S.J., Raubenheimer, D., and Skilton, M.R. (2023). Multi-nutrient analysis of dietary macronutrients with all-cause, cardiovascular, and cancer mortality: Data from NHANES 1999\u20132014. Nutrients, 15.","DOI":"10.3390\/nu15020345"},{"key":"ref_358","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jgr.2024.04.005","article-title":"Ginseng as a therapeutic target to alleviate gut and brain diseases via microbiome regulation","volume":"49","author":"Iqbal","year":"2025","journal-title":"J. Ginseng Res."},{"key":"ref_359","doi-asserted-by":"crossref","unstructured":"Scazzocchio, B., Minghetti, L., and D\u2019Archivio, M. (2020). Interaction between gut microbiota and curcumin: A new key of understanding for the health effects of curcumin. Nutrients, 12.","DOI":"10.3390\/nu12092499"},{"key":"ref_360","doi-asserted-by":"crossref","unstructured":"Morato-Mart\u00ednez, M., L\u00f3pez-Plaza, B., Santurino, C., Palma-Milla, S., and G\u00f3mez-Candela, C. (2020). A dairy product to reconstitute enriched with bioactive nutrients stops bone loss in high-risk menopausal women without pharmacological treatment. Nutrients, 12.","DOI":"10.3390\/nu12082203"},{"key":"ref_361","doi-asserted-by":"crossref","unstructured":"Mouchtoglou, C., Cherlet, M., Dehau, T., Aluwe, M., Ducatelle, R., Goossens, E., Croubels, S., and Van Immerseel, F. (2025). A Low Dose of Berberine Is Metabolized in Weaned Piglets Without Major Changes to Gut Morphology or Gut Microbiota. Animals, 15.","DOI":"10.3390\/ani15162450"},{"key":"ref_362","doi-asserted-by":"crossref","first-page":"154496","DOI":"10.1016\/j.phymed.2022.154496","article-title":"Clinical efficacy of Jingyin granules, a Chinese patent medicine, in treating patients infected with coronavirus disease 2019","volume":"108","author":"Chen","year":"2023","journal-title":"Phytomedicine"},{"key":"ref_363","doi-asserted-by":"crossref","unstructured":"Wang, H., Zhao, T., Liu, Z., Ma, J., Li, X., Huang, X., and Li, B. (2023). The neuromodulatory effects of flavonoids and gut Microbiota through the gut-brain axis. Front. Cell. Infect. Microbiol., 13.","DOI":"10.3389\/fcimb.2023.1197646"},{"key":"ref_364","doi-asserted-by":"crossref","unstructured":"Shen, C.-L., Santos, J.M., Elmassry, M.M., Chen, F., Ji, G., Presto, P., Kiritoshi, T., Liu, X., and Neugebauer, V. (2025). Crosstalk Among Gut Microbiota, Fecal Metabolites, and Amygdala Neuropathology Genes After Ginger Polyphenol Administration in Female Rats with Neuropathic Pain: Evidence for Microbiota\u2013Gut\u2013Brain Connection. Nutrients, 17.","DOI":"10.3390\/nu17091444"},{"key":"ref_365","doi-asserted-by":"crossref","unstructured":"Shang, A., Cao, S.-Y., Xu, X.-Y., Gan, R.-Y., Tang, G.-Y., Corke, H., Mavumengwana, V., and Li, H.-B. (2019). Bioactive compounds and biological functions of garlic (Allium sativum L.). Foods, 8.","DOI":"10.3390\/foods8070246"},{"key":"ref_366","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/nrn3346","article-title":"Mind-altering microorganisms: The impact of the gut microbiota on brain and behaviour","volume":"13","author":"Cryan","year":"2012","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_367","doi-asserted-by":"crossref","first-page":"e14515","DOI":"10.1111\/cbdd.14515","article-title":"Role of autophagy and proteostasis in neurodegenerative diseases: Exploring the therapeutic interventions","volume":"103","author":"Panwar","year":"2024","journal-title":"Chem. Biol. Drug Des."},{"key":"ref_368","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/s41418-020-00667-x","article-title":"Ubiquitin signaling in neurodegenerative diseases: An autophagy and proteasome perspective","volume":"28","author":"Youle","year":"2021","journal-title":"Cell Death Differ."},{"key":"ref_369","doi-asserted-by":"crossref","unstructured":"Yu, X., Ni, Q., Han, L., Zhang, S., Xu, H., Xie, J., and Liu, Y. (2026). Decode the Ubiquitinome in Parkinson\u2019s Disease: From Pathological Aggregates to Targeted DUB Therapeutics. Neurosci. Bull.","DOI":"10.1007\/s12264-026-01613-6"},{"key":"ref_370","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1126\/science.aax3769","article-title":"Cellular quality control by the ubiquitin-proteasome system and autophagy","volume":"366","author":"Pohl","year":"2019","journal-title":"Science"},{"key":"ref_371","doi-asserted-by":"crossref","unstructured":"Mueed, Z., Tandon, P., Maurya, S.K., Deval, R., Kamal, M.A., and Poddar, N.K. (2019). Tau and mTOR: The hotspots for multifarious diseases in Alzheimer\u2019s development. Front. Neurosci., 12.","DOI":"10.3389\/fnins.2018.01017"},{"key":"ref_372","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1002\/iub.2369","article-title":"Boosting the autophagy-lysosomal pathway by phytochemicals: A potential therapeutic strategy against Alzheimer\u2019s disease","volume":"72","author":"Nourbakhsh","year":"2020","journal-title":"IUBMB Life"},{"key":"ref_373","doi-asserted-by":"crossref","unstructured":"Cuanalo-Contreras, K., and Moreno-Gonzalez, I. (2019). Natural products as modulators of the proteostasis machinery: Implications in neurodegenerative diseases. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20194666"},{"key":"ref_374","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/s12035-013-8505-8","article-title":"Targeting the mTOR signaling network for Alzheimer\u2019s disease therapy","volume":"49","author":"Wang","year":"2014","journal-title":"Mol. Neurobiol."},{"key":"ref_375","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1126\/science.1074069","article-title":"Alzheimer\u2019s disease is a synaptic failure","volume":"298","author":"Selkoe","year":"2002","journal-title":"Science"},{"key":"ref_376","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1093\/jpp\/rgad048","article-title":"Spotlight on Coenzyme Q10 in scopolamine-induced Alzheimer\u2019s disease: Oxidative stress\/PI3K\/AKT\/GSK 3\u00df\/CREB\/BDNF\/TrKB","volume":"75","author":"Abuelezz","year":"2023","journal-title":"J. Pharm. Pharmacol."},{"key":"ref_377","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/dneu.20765","article-title":"Postsynaptic BDNF-TrkB signaling in synapse maturation, plasticity, and disease","volume":"70","author":"Yoshii","year":"2010","journal-title":"Dev. Neurobiol."},{"key":"ref_378","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.neuroscience.2024.12.032","article-title":"Chrysin modulates the BDNF\/TrkB\/AKT\/Creb neuroplasticity signaling pathway: Acting in the improvement of cognitive flexibility and declarative, working and aversive memory deficits caused by hypothyroidism in C57BL\/6 female mice","volume":"566","author":"Bortolotto","year":"2025","journal-title":"Neuroscience"},{"key":"ref_379","unstructured":"Razi, U., and Rahman, A. (2026). Phytochemicals in Neurodegenerative Diseases. Nourishing the Brain: Diet and Nutrition Strategies in Managing Neurological Disorders, Springer."},{"key":"ref_380","doi-asserted-by":"crossref","unstructured":"Cipriano, G.L., Raffaele, I., Floramo, A., Argento, V., Astorino, M.F., Lui, M., Calabr\u00f2, M., and Anchesi, I. (2026). Phytochemical and Fungal Bioactive Compounds in the \u201cBrain Health Triad\u201d: A Narrative Review on Neurostimulating, Neurotrophic, and Neuroprotective Synergy. Int. J. Mol. Sci., 27.","DOI":"10.3390\/ijms27083607"},{"key":"ref_381","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s13036-024-00419-2","article-title":"Nonthermal biocompatible plasma in stimulating osteogenic differentiation by targeting p38\/FOXO1 and PI3K\/AKT pathways in hBMSCs","volume":"18","author":"Akter","year":"2024","journal-title":"J. Biol. Eng."},{"key":"ref_382","doi-asserted-by":"crossref","first-page":"15075","DOI":"10.1007\/s00210-025-04298-2","article-title":"Phytochemicals encouraging neurotrophic pathways: Brain-derived neurotrophic factors as molecular targets in depression","volume":"398","author":"Karad","year":"2025","journal-title":"Naunyn-Schmiedeberg\u2019s Arch. Pharmacol."},{"key":"ref_383","doi-asserted-by":"crossref","unstructured":"Xiao, X., Yan, X., Chunhua, L., and Yang, Y. (2026). Metabolic dysfunction and mitochondrial failure in Alzheimer\u2019s disease: Integrating pathophysiology, clinical evidence and emerging interventions. Front. Neurol., 17.","DOI":"10.3389\/fneur.2026.1772036"},{"key":"ref_384","doi-asserted-by":"crossref","unstructured":"Xiang, Y., Gu, Q., and Liu, D. (2025). Brain endothelial cells in blood\u2013brain barrier regulation and neurological therapy. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26125843"},{"key":"ref_385","doi-asserted-by":"crossref","unstructured":"Alkhalifa, A.E., Al-Ghraiybah, N.F., Odum, J., Shunnarah, J.G., Austin, N., and Kaddoumi, A. (2023). Blood\u2013brain barrier breakdown in Alzheimer\u2019s disease: Mechanisms and targeted strategies. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms242216288"},{"key":"ref_386","doi-asserted-by":"crossref","unstructured":"Liu, Y., Chen, Z., Li, A., Liu, R., Yang, H., and Xia, X. (2022). The phytochemical potential for brain disease therapy and the possible nanodelivery solutions for brain access. Front. Oncol., 12.","DOI":"10.3389\/fonc.2022.936054"},{"key":"ref_387","doi-asserted-by":"crossref","unstructured":"Tsai, M.-M., Chen, J.-L., Lee, T.-H., Liu, H., Shanmugam, V., and Hsieh, H.-L. (2022). Brain protective effect of resveratrol via ameliorating interleukin-1\u03b2-induced MMP-9-mediated disruption of ZO-1 arranged integrity. Biomedicines, 10.","DOI":"10.3390\/biomedicines10061270"},{"key":"ref_388","doi-asserted-by":"crossref","first-page":"2470482","DOI":"10.1080\/21688370.2025.2470482","article-title":"Claudin-1 impairs blood\u2013brain barrier by downregulating endothelial junctional proteins in traumatic brain injury","volume":"13","author":"Gowrikumar","year":"2025","journal-title":"Tissue Barriers"},{"key":"ref_389","first-page":"1262","article-title":"Molecular mechanisms underlying the neuroprotective effects of polyphenols: Implications for cognitive function","volume":"24","author":"Godos","year":"2025","journal-title":"EXCLI J."},{"key":"ref_390","doi-asserted-by":"crossref","unstructured":"Naim, A., Farooqui, A.M., Khan, M.I., Akhtar, J., Ahmad, A., Ashique, S., and Islam, A. (2026). Nanoengineered phytochemicals overcome blood\u2013brain barrier constraints in neurodegenerative disorders. Front. Neurol., 17.","DOI":"10.3389\/fneur.2026.1792829"},{"key":"ref_391","doi-asserted-by":"crossref","unstructured":"Naqvi, S., Panghal, A., and Flora, S. (2020). Nanotechnology: A promising approach for delivery of neuroprotective drugs. Front. Neurosci., 14.","DOI":"10.3389\/fnins.2020.00494"},{"key":"ref_392","doi-asserted-by":"crossref","unstructured":"Batool, M., Ain, Q.U., Rauf, S., David, M., Jalil, S., Afzal, M., Zulfiqar, S., and Bibi, M. (2025). Nanotechnology-Based Delivery of Natural Products. Natural Products in Biomedical Research, FahumSci.","DOI":"10.61748\/NPBR.2025\/21"},{"key":"ref_393","doi-asserted-by":"crossref","first-page":"eabb8255","DOI":"10.1126\/science.abb8255","article-title":"Tau: Enabler of diverse brain disorders and target of rapidly evolving therapeutic strategies","volume":"371","author":"Chang","year":"2021","journal-title":"Science"},{"key":"ref_394","doi-asserted-by":"crossref","first-page":"86","DOI":"10.3934\/Neuroscience.2021005","article-title":"The biological pathways of Alzheimer disease: A review","volume":"8","author":"Rinaldi","year":"2021","journal-title":"AIMS Neurosci."},{"key":"ref_395","doi-asserted-by":"crossref","unstructured":"Aktary, N., Jeong, Y., Oh, S., Shin, Y., Sung, Y., Rahman, M., Ramos Santiago, L., Choi, J., Song, H.G., and Nurkolis, F. (2025). Unveiling the therapeutic potential of natural products in Alzheimer\u2019s disease: Insights from in vitro, in vivo, and clinical studies. Front. Pharmacol., 16.","DOI":"10.3389\/fphar.2025.1601712"},{"key":"ref_396","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.2174\/1386207323999201110192942","article-title":"Herbal medicine: Clinical perspective and regulatory status","volume":"24","author":"Barkat","year":"2021","journal-title":"Comb. Chem. High Throughput Screen."},{"key":"ref_397","doi-asserted-by":"crossref","first-page":"5578574","DOI":"10.1155\/2021\/5578574","article-title":"Therapeutic potential of phytoconstituents in management of Alzheimer\u2019s disease","volume":"2021","author":"Singh","year":"2021","journal-title":"Evid.-Based Complement. Altern. Med."},{"key":"ref_398","first-page":"1","article-title":"Bioactive compounds and traditional herbal medicine: Promising approaches for the treatment of dementia","volume":"11","author":"Alzobaidi","year":"2021","journal-title":"Degener. Neurol. Neuromuscul. Dis."},{"key":"ref_399","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1002\/med.21434","article-title":"Drugs in clinical trials for Alzheimer\u2019s disease: The major trends","volume":"37","author":"Bachurin","year":"2017","journal-title":"Med. Res. Rev."},{"key":"ref_400","doi-asserted-by":"crossref","unstructured":"Tohda, C., Yang, X., Matsui, M., Inada, Y., Kadomoto, E., Nakada, S., Watari, H., and Shibahara, N. (2017). Diosgenin-rich yam extract enhances cognitive function: A placebo-controlled, randomized, double-blind, crossover study of healthy adults. Nutrients, 9.","DOI":"10.3390\/nu9101160"},{"key":"ref_401","doi-asserted-by":"crossref","first-page":"19914","DOI":"10.1038\/s41598-020-76938-x","article-title":"Effect of desalted Salicornia europaea L. ethanol extract (PM-EE) on the subjects complaining memory dysfunction without dementia: A 12 week, randomized, double-blind, placebo-controlled clinical trial","volume":"10","author":"Lee","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_402","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1080\/19390211.2017.1284970","article-title":"Efficacy and safety of Ashwagandha (Withania somnifera (L.) Dunal) root extract in improving memory and cognitive functions","volume":"14","author":"Choudhary","year":"2017","journal-title":"J. Diet. Suppl."},{"key":"ref_403","doi-asserted-by":"crossref","unstructured":"Kennedy, D., Wightman, E., Khan, J., Grothe, T., and Jackson, P. (2019). The acute and chronic cognitive and cerebral blood-flow effects of nepalese pepper (Zanthoxylum armatum dc.) extract\u2014A randomized, double-blind, placebo-controlled study in healthy humans. Nutrients, 11.","DOI":"10.3390\/nu11123022"},{"key":"ref_404","doi-asserted-by":"crossref","first-page":"677","DOI":"10.2174\/1573401319666230821102546","article-title":"Implications of herbal components in the treatment of neurological disorders","volume":"20","author":"Ali","year":"2024","journal-title":"Curr. Nutr. Food Sci."},{"key":"ref_405","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/s41392-023-01486-5","article-title":"Role of neuroinflammation in neurodegeneration development","volume":"8","author":"Zhang","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_406","doi-asserted-by":"crossref","first-page":"e70496","DOI":"10.1002\/fsn3.70496","article-title":"Polyphenols and Alzheimer\u2019s Disease: A Review on Molecular and Therapeutic Insights with In Silico Support","volume":"13","author":"Chen","year":"2025","journal-title":"Food Sci. Nutr."},{"key":"ref_407","doi-asserted-by":"crossref","unstructured":"Lehoczki, A., Fekete, M., Jarecsny, T., Z\u00e1b\u00f3, V., Szappanos, \u00c1., Cs\u00edp\u0151, T., Lip\u00e9cz, \u00c1., Major, D., Fazekas-Pongor, V., and Varga, P. (2025). The Neuroprotective Role of Curcumin: From Molecular Pathways to Clinical Translation\u2014A Narrative Review. Nutrients, 17.","DOI":"10.3390\/nu17172884"},{"key":"ref_408","doi-asserted-by":"crossref","unstructured":"Bu\u010devi\u0107 Popovi\u0107, V., Karahmet Farhat, E., Banjari, I., Jeli\u010di\u0107 Kadi\u0107, A., and Puljak, L. (2024). Bioavailability of oral curcumin in systematic reviews: A methodological study. Pharmaceuticals, 17.","DOI":"10.3390\/ph17020164"},{"key":"ref_409","doi-asserted-by":"crossref","first-page":"24515","DOI":"10.1038\/s41598-025-08665-0","article-title":"Pharmacokinetic evaluation of two oral Resveratrol formulations in a randomized, open-label, crossover study in healthy fasting subjects","volume":"15","author":"Wang","year":"2025","journal-title":"Sci. Rep."},{"key":"ref_410","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.7150\/ijbs.90982","article-title":"Polyphenols targeting NF-\u03baB pathway in neurological disorders: What we know so far?","volume":"20","author":"Shao","year":"2024","journal-title":"Int. J. Biol. Sci."},{"key":"ref_411","first-page":"76","article-title":"Herbal Medicines in Autism Spectrum Disorder: Therapeutic Potential, Plant Components, and Dosage Guidelines","volume":"31","author":"Aldekhail","year":"2025","journal-title":"Altern. Ther. Health Med."},{"key":"ref_412","doi-asserted-by":"crossref","unstructured":"Monagas, M., Brendler, T., Brinckmann, J., Dentali, S., Gafner, S., Giancaspro, G., Johnson, H., Kababick, J., Ma, C., and Oketch-Rabah, H. (2022). Understanding plant to extract ratios in botanical extracts. Front. Pharmacol., 13.","DOI":"10.3389\/fphar.2022.981978"},{"key":"ref_413","doi-asserted-by":"crossref","unstructured":"Liang, N., Chen, Y., Yang, S., Liang, C., Gao, L., Wang, S., Wang, Y., Zhang, Z., and Shi, N. (2022). Chinese herbal medicine for mild cognitive impairment: A systematic review of randomized controlled trials. Front. Neurol., 13.","DOI":"10.3389\/fneur.2022.903224"},{"key":"ref_414","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/mnfr.200900437","article-title":"Resveratrol bioavailability and toxicity in humans","volume":"54","author":"Cottart","year":"2010","journal-title":"Mol. Nutr. Food Res."},{"key":"ref_415","doi-asserted-by":"crossref","unstructured":"Paliwal, H., Prajapati, B.G., and Srichana, T. (2025). Nanotechnology-Based Drug Delivery Systems for the Treatment of Neurodegenerative Disorders. Nanomedicine for Neurodegenerative Disorders, Apple Academic Press.","DOI":"10.1201\/9781003486565-6"},{"key":"ref_416","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.2165\/11317010-000000000-00000","article-title":"Interactions between herbal medicines and prescribed drugs: An updated systematic review","volume":"69","author":"Izzo","year":"2009","journal-title":"Drugs"},{"key":"ref_417","doi-asserted-by":"crossref","first-page":"589","DOI":"10.3233\/JAD-140837","article-title":"Efficacy and adverse effects of ginkgo biloba for cognitive impairment and dementia: A systematic review and meta-analysis","volume":"43","author":"Tan","year":"2014","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_418","doi-asserted-by":"crossref","first-page":"3614","DOI":"10.2174\/0109298673428595251209114801","article-title":"Herbal Medicines and Drugs Interactions: Cytochrome P450 Responsibility","volume":"33","author":"Shanaida","year":"2026","journal-title":"Curr. Med. Chem."},{"key":"ref_419","doi-asserted-by":"crossref","first-page":"6539","DOI":"10.1038\/s41598-026-37696-4","article-title":"Patterns of herbal medicine utilization for hypertension during the Sudanese crisis of 2025","volume":"16","author":"Sidahmed","year":"2026","journal-title":"Sci. Rep."},{"key":"ref_420","doi-asserted-by":"crossref","first-page":"15","DOI":"10.33545\/26649675.2025.v7.i1a.59","article-title":"Liver failure induced by hepatotoxic drugs: Prevention and treatment strategies","volume":"7","author":"Bakare","year":"2025","journal-title":"Int. J. Hepatol. Sci."},{"key":"ref_421","first-page":"1","article-title":"Herbs Derived Bioactive Compounds and their Potential for the Treatment of Neurological Disorders","volume":"16","author":"Dubey","year":"2022","journal-title":"Clin. Schizophr. Relat. Psychoses"},{"key":"ref_422","doi-asserted-by":"crossref","first-page":"6565396","DOI":"10.1155\/2020\/6565396","article-title":"Natural products and their bioactive compounds: Neuroprotective potentials against neurodegenerative diseases","volume":"2020","author":"Sirajudeen","year":"2020","journal-title":"Evid.-Based Complement. Altern. Med."},{"key":"ref_423","doi-asserted-by":"crossref","first-page":"20626","DOI":"10.1038\/s41598-022-23999-9","article-title":"Analysis toxicity by different methods and anxiolytic effect of the aqueous extract Lippia sidoides Cham","volume":"12","author":"Camilo","year":"2022","journal-title":"Sci. Rep."},{"key":"ref_424","doi-asserted-by":"crossref","unstructured":"Elshafie, H.S., Camele, I., and Mohamed, A.A. (2023). A comprehensive review on the biological, agricultural and pharmaceutical properties of secondary metabolites based-plant origin. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24043266"},{"key":"ref_425","doi-asserted-by":"crossref","first-page":"112175","DOI":"10.1016\/j.biopha.2021.112175","article-title":"Withania somnifera (L.) Dunal (Ashwagandha): A comprehensive review on ethnopharmacology, pharmacotherapeutics, biomedicinal and toxicological aspects","volume":"143","author":"Paul","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"ref_426","doi-asserted-by":"crossref","first-page":"112876","DOI":"10.1016\/j.jep.2020.112876","article-title":"Ashwagandha in brain disorders: A review of recent developments","volume":"257","author":"Zahiruddin","year":"2020","journal-title":"J. Ethnopharmacol."},{"key":"ref_427","doi-asserted-by":"crossref","unstructured":"Mikulska, P., Malinowska, M., Ignacyk, M., Szustowski, P., Nowak, J., Pesta, K., Szel\u0105g, M., Szklanny, D., Judasz, E., and Kaczmarek, G. (2023). Ashwagandha (Withania somnifera)\u2014Current research on the health-promoting activities: A narrative review. Pharmaceutics, 15.","DOI":"10.3390\/pharmaceutics15041057"},{"key":"ref_428","unstructured":"Srikantha, S., and Jain, A. (2024). Investigation of water-soluble coenzyme-Q10 combined with root extract of ashwagandha as a potential therapy for Alzheimer\u2019s Disease. UWill Discover Student Research Conference, University of Windsor."},{"key":"ref_429","doi-asserted-by":"crossref","unstructured":"Lerose, V., Ponticelli, M., Benedetto, N., Carlucci, V., Lela, L., Tzvetkov, N.T., and Milella, L. (2024). Withania somnifera (L.) Dunal, a Potential Source of Phytochemicals for Treating Neurodegenerative Diseases: A Systematic Review. Plants, 13.","DOI":"10.3390\/plants13060771"},{"key":"ref_430","first-page":"359","article-title":"Neuropsychopharmacological effects of the ayurvedic nootroplc Bacopa monnlera linn. (Brahmi)","volume":"29","author":"Singh","year":"1997","journal-title":"Indian J. Pharmacol."},{"key":"ref_431","doi-asserted-by":"crossref","unstructured":"Valotto Neto, L.J., Reverete de Araujo, M., Moretti Junior, R.C., Mendes Machado, N., Joshi, R.K., dos Santos Buglio, D., Barbalho Lamas, C., Direito, R., Fornari Laurindo, L., and Tanaka, M. (2024). Investigating the neuroprotective and cognitive-enhancing effects of Bacopa monnieri: A systematic review focused on inflammation, oxidative stress, mitochondrial dysfunction, and apoptosis. Antioxidants, 13.","DOI":"10.3390\/antiox13040393"},{"key":"ref_432","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1159\/000475900","article-title":"Neurocognitive effect of nootropic drug Brahmi (Bacopa monnieri) in Alzheimer\u2019s disease","volume":"24","author":"Chaudhari","year":"2017","journal-title":"Ann. Neurosci."},{"key":"ref_433","doi-asserted-by":"crossref","first-page":"102990","DOI":"10.1016\/j.explore.2024.02.008","article-title":"Evaluating the effects of Bacopa monnieri on cognitive performance and sleep quality of patients with mild cognitive impairment: A triple-blinded, randomized, placebo-controlled trial","volume":"20","author":"Delfan","year":"2024","journal-title":"Explore"},{"key":"ref_434","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1007\/s11033-021-06236-w","article-title":"Neuroprotection with Bacopa monnieri\u2014A review of experimental evidence","volume":"48","author":"Shalini","year":"2021","journal-title":"Mol. Biol. Rep."},{"key":"ref_435","doi-asserted-by":"crossref","unstructured":"Batiha, G.E.-S., Magdy Beshbishy, A., Wasef, L., Elewa, Y.H., Abd El-Hack, M.E., Taha, A.E., Al-Sagheer, A.A., Devkota, H.P., and Tufarelli, V. (2020). Uncaria tomentosa (Willd. ex Schult.) DC.: A review on chemical constituents and biological activities. Appl. Sci., 10.","DOI":"10.3390\/app10082668"},{"key":"ref_436","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s13020-021-00514-2","article-title":"Comparison of the chemical constituents and anti-Alzheimer\u2019s disease effects of Uncaria rhynchophylla and Uncaria tomentosa","volume":"16","author":"Xu","year":"2021","journal-title":"Chin. Med."},{"key":"ref_437","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0022-3565(24)37225-8","article-title":"Synthetic combined superoxide dismutase\/catalase mimetics are protective as a delayed treatment in a rat stroke model: A key role for reactive oxygen species in ischemic brain injury","volume":"284","author":"Baker","year":"1998","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_438","doi-asserted-by":"crossref","first-page":"951415","DOI":"10.1155\/2013\/951415","article-title":"Cerebroprotective effect of Moringa oleifera against focal ischemic stroke induced by middle cerebral artery occlusion","volume":"2013","author":"Kirisattayakul","year":"2013","journal-title":"Oxidative Med. Cell. Longev."},{"key":"ref_439","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.fshw.2016.04.001","article-title":"Moringa oleifera: A review on nutritive importance and its medicinal application","volume":"5","author":"Gopalakrishnan","year":"2016","journal-title":"Food Sci. Hum. Wellness"},{"key":"ref_440","doi-asserted-by":"crossref","first-page":"14358","DOI":"10.1021\/acs.jafc.1c04581","article-title":"Moringa oleifera: A tree of life as a promising medicinal plant for neurodegenerative diseases","volume":"69","author":"Ghimire","year":"2021","journal-title":"J. Agric. Food Chem."},{"key":"ref_441","doi-asserted-by":"crossref","first-page":"FSO961","DOI":"10.2144\/fsoa-2023-0255","article-title":"In silico and pharmacokinetic studies of glucomoringin from Moringa oleifera root for Alzheimer\u2019s disease like pathology","volume":"10","author":"Manogna","year":"2024","journal-title":"Future Sci. OA"},{"key":"ref_442","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jgr.2024.02.002","article-title":"Emerging evidence that ginseng components improve cognition in subjective memory impairment, mild cognitive impairment, and early Alzheimer\u2019s disease dementia","volume":"48","author":"Lee","year":"2024","journal-title":"J. Ginseng Res."},{"key":"ref_443","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1142\/S0192415X25500028","article-title":"Korean Red Ginseng Marc-Derived Gintonin Improves Alzheimer\u2019s Cognitive Dysfunction by Upregulating LPAR1","volume":"53","author":"Ha","year":"2025","journal-title":"Am. J. Chin. Med."},{"key":"ref_444","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jgr.2023.08.003","article-title":"Effects of Red ginseng on neuroinflammation in neurodegenerative diseases","volume":"48","author":"Lee","year":"2024","journal-title":"J. Ginseng Res."},{"key":"ref_445","doi-asserted-by":"crossref","first-page":"100480","DOI":"10.1016\/j.prmcm.2024.100480","article-title":"A Systemic Review of Ginseng and Its Activity on Coronary Heart Disease","volume":"12","author":"Parmar","year":"2024","journal-title":"Pharmacol. Res.-Mod. Chin. Med."},{"key":"ref_446","doi-asserted-by":"crossref","first-page":"41","DOI":"10.2174\/1386207320666171123201910","article-title":"Identification of human acetylcholinesterase inhibitors from the constituents of EGb761 by modeling docking and molecular dynamics simulations","volume":"21","author":"Zhang","year":"2018","journal-title":"Comb. Chem. High Throughput Screen."},{"key":"ref_447","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1080\/15287394.2019.1686215","article-title":"Mechanisms associated with protective effects of ginkgo biloba leaf extracton in rat cerebral ischemia reperfusion injury","volume":"82","author":"Song","year":"2019","journal-title":"J. Toxicol. Environ. Health Part A"},{"key":"ref_448","doi-asserted-by":"crossref","unstructured":"Nowak, A., Kojder, K., Zielonka-Brzezicka, J., Wr\u00f3bel, J., Bosiacki, M., Fabia\u0144ska, M., Wr\u00f3bel, M., So\u0142ek-Pastuszka, J., and Klimowicz, A. (2021). The use of Ginkgo biloba L. as a neuroprotective agent in the Alzheimer\u2019s disease. Front. Pharmacol., 12.","DOI":"10.3389\/fphar.2021.775034"},{"key":"ref_449","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1142\/S0192415X24500277","article-title":"Ginkgo biloba and Its Chemical Components in the Management of Alzheimer\u2019s Disease","volume":"52","author":"Peng","year":"2024","journal-title":"Am. J. Chin. Med."},{"key":"ref_450","doi-asserted-by":"crossref","unstructured":"Pagotto, G.L.d.O., Santos, L.M.O.d., Osman, N., Lamas, C.B., Laurindo, L.F., Pomini, K.T., Guissoni, L.M., Lima, E.P.d., Goulart, R.d.A., and Catharin, V.M.S. (2024). Ginkgo biloba: A Leaf of Hope in the Fight against Alzheimer\u2019s Dementia: Clinical Trial Systematic Review. Antioxidants, 13.","DOI":"10.20944\/preprints202404.0852.v1"},{"key":"ref_451","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1002\/ptr.6178","article-title":"Liquorice (Glycyrrhiza glabra): A phytochemical and pharmacological review","volume":"32","author":"Pastorino","year":"2018","journal-title":"Phytother. Res."},{"key":"ref_452","first-page":"132","article-title":"Glycyrrhiza glabra (Liquorice)-a potent medicinal herb","volume":"2","author":"Damle","year":"2014","journal-title":"Int. J. Herb. Med."},{"key":"ref_453","first-page":"47","article-title":"Review of Pharmacotherapeutic Targets in Alzheimer\u2019s Disease and Its Management Using Traditional Medicinal Plants","volume":"2024","author":"Tripathi","year":"2024","journal-title":"Degener. Neurol. Neuromuscul. Dis."},{"key":"ref_454","doi-asserted-by":"crossref","first-page":"100030","DOI":"10.1016\/j.prmcm.2021.100030","article-title":"Phytotherapy: A promising approach for the treatment of Alzheimer\u2019s disease","volume":"2","author":"John","year":"2022","journal-title":"Pharmacol. Res.-Mod. Chin. Med."},{"key":"ref_455","doi-asserted-by":"crossref","unstructured":"Cole, G.M., Teter, B., and Frautschy, S.A. (2007). Neuroprotective effects of curcumin. The Molecular Targets and Therapeutic Uses of Curcumin in Health and Disease, Springer.","DOI":"10.1007\/978-0-387-46401-5_8"},{"key":"ref_456","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1016\/j.acthis.2014.09.009","article-title":"Histological studies of neuroprotective effects of Curcuma longa Linn. on neuronal loss induced by dexamethasone treatment in the rat hippocampus","volume":"116","author":"Issuriya","year":"2014","journal-title":"Acta Histochem."},{"key":"ref_457","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1097\/FJC.0000000000000110","article-title":"Curcuma oil reduces endothelial cell-mediated inflammation in postmyocardial ischemia\/reperfusion in rats","volume":"64","author":"Manhas","year":"2014","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"ref_458","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1002\/ptr.5036","article-title":"Curcumin I mediates neuroprotective effect through attenuation of quinoprotein formation, p-p38 MAPK expression, and caspase-3 activation in 6-hydroxydopamine treated SH-SY5Y cells","volume":"28","author":"Meesarapee","year":"2014","journal-title":"Phytother. Res."},{"key":"ref_459","doi-asserted-by":"crossref","unstructured":"Omosa, L., Midiwo, J., and Kuete, V. (2017). \u00a0Curcuma longa. Medicinal Spices and Vegetables from Africa, Elsevier.","DOI":"10.1016\/B978-0-12-809286-6.00019-4"},{"key":"ref_460","doi-asserted-by":"crossref","unstructured":"Meneses, A.K.S., Salazar, G.J.T., de Freitas, M.M., and de Lima, S.G. (2024). Curcuma longa: A Natural Ally in Alzheimer\u2019s Disease Management. Curcumin and Neurodegenerative Diseases: From Traditional to Translational Medicines, Springer.","DOI":"10.1007\/978-981-99-7731-4_9"},{"key":"ref_461","doi-asserted-by":"crossref","first-page":"7036","DOI":"10.1021\/jf0614948","article-title":"Pistachio skin phenolics are destroyed by bleaching resulting in reduced antioxidative capacities","volume":"54","author":"Seeram","year":"2006","journal-title":"J. Agric. Food Chem."},{"key":"ref_462","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1155\/2013\/219815","article-title":"A review of their traditional uses, phytochemistry, and pharmacology","volume":"2013","author":"Bozorgi","year":"2013","journal-title":"Sci. World J."},{"key":"ref_463","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.brainres.2014.04.038","article-title":"Oleic acid synthesized by stearoyl-CoA desaturase (SCD-1) in the lateral periventricular zone of the developing rat brain mediates neuronal growth, migration and the arrangement of prospective synapses","volume":"1570","author":"Tello","year":"2014","journal-title":"Brain Res."},{"key":"ref_464","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.bbi.2015.09.012","article-title":"Chronic alpha-linolenic acid treatment alleviates age-associated neuropathology: Roles of PERK\/eIF2\u03b1 signaling pathway","volume":"57","author":"Gao","year":"2016","journal-title":"Brain Behav. Immun."},{"key":"ref_465","doi-asserted-by":"crossref","first-page":"92","DOI":"10.4103\/2277-9175.156656","article-title":"Pistachio supplementation attenuates motor and cognition impairments induced by cisplatin or vincristine in rats","volume":"4","author":"Golchin","year":"2015","journal-title":"Adv. Biomed. Res."},{"key":"ref_466","doi-asserted-by":"crossref","unstructured":"Hossain, M.M.A.S., Sarker, J., Rahman, S.A., and Rahman, M.R.M. (2015). In vitro antioxidant and cholinesterase inhibitory activities of methanolic fruit extract of Phyllanthus acidus. BMC Complement. Med. Ther., 15.","DOI":"10.1186\/s12906-015-0930-y"},{"key":"ref_467","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1159\/000449482","article-title":"Exploring the effect of Phyllanthus emblica L. on cognitive performance, brain antioxidant markers and acetylcholinesterase activity in rats: Promising natural gift for the mitigation of Alzheimer\u2019s disease","volume":"23","author":"Uddin","year":"2016","journal-title":"Ann. Neurosci."},{"key":"ref_468","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/S0091-3057(02)00777-3","article-title":"Modulation of mood and cognitive performance following acute administration of Melissa officinalis (lemon balm)","volume":"72","author":"Kennedy","year":"2002","journal-title":"Pharmacol. Biochem. Behav."},{"key":"ref_469","doi-asserted-by":"crossref","unstructured":"Kaczmarek-Kryszak, K.A., Dobrzy\u0144ska, M., Banaszak, M., and Drzyma\u0142a-Czy\u017c, S. (2026). A comprehensive systematic review of human trials investigating herbal treatments for Alzheimer\u2019s disease and dementia. Acta Neuropsychiatr., online.","DOI":"10.1017\/neu.2026.10085"},{"key":"ref_470","first-page":"22","article-title":"Edible plants: Promising source for prevention and management of Parkinson\u2019s and Alzheimer\u2019s disease","volume":"1","author":"Balkrishna","year":"2026","journal-title":"Arch. Alzheimer\u2019s Park. Dis."},{"key":"ref_471","first-page":"367","article-title":"Improving effects of the mushroom Yamabushitake (Hericium erinaceus) on mild cognitive impairment: A double-blind placebo-controlled clinical trial","volume":"23","author":"Mori","year":"2009","journal-title":"Phytother. Res. Int. J. Devoted Pharmacol. Toxicol. Eval. Nat. Prod. Deriv."},{"key":"ref_472","doi-asserted-by":"crossref","unstructured":"Daoust, J., Farrar, S., Grant, A., Erfe, M., Oliver, P., Luna, V., Moos, J., and Craft, N. (2026). A randomized, double blind, placebo controlled study evaluating the impact of Hericium erinaceus (Lion\u2019s Mane) on cognitive performance and subjective wellbeing. medRxiv.","DOI":"10.64898\/2026.04.13.26350781"},{"key":"ref_473","first-page":"13","article-title":"Antioxidant, anti-inflammatory and cytoprotective effects of crocin, a bioactive constituent of saffron, in Alzheimer\u2019s and Parkinson\u2019s diseases with a focus on molecular mechanisms: A systematic review","volume":"16","author":"Hadipour","year":"2026","journal-title":"Avicenna J. Phytomed."},{"key":"ref_474","doi-asserted-by":"crossref","unstructured":"Maggi, M.A., Mastromartino, R., Piccardi, M., Minnella, A.M., Marangoni, D., Di Marco, S., Falsini, B., and Bisti, S. (2026). Saffron as a Retinal Neuroprotectant: A Narrative Review of Preclinical Studies and Clinical Results. Antioxidants, 15.","DOI":"10.3390\/antiox15040501"},{"key":"ref_475","doi-asserted-by":"crossref","first-page":"E440","DOI":"10.1017\/S0029665120003882","article-title":"Curcumin improves hippocampal function in healthy older adults: A three month randomised controlled trial","volume":"79","author":"Scholey","year":"2020","journal-title":"Proc. Nutr. Soc."},{"key":"ref_476","doi-asserted-by":"crossref","unstructured":"Zeppa, L., Aguzzi, C., and Morelli, M.B. (2025). Exploring the Therapeutic Potential of Natural Compounds and Plant Extracts in Human Health. Biomolecules, 15.","DOI":"10.3390\/biom15060774"},{"key":"ref_477","doi-asserted-by":"crossref","unstructured":"Deding, U., Baatrup, G., Kaalby, L., and Kobaek-Larsen, M. (2023). Carrot intake and risk of developing cancer: A prospective cohort study. Nutrients, 15.","DOI":"10.3390\/nu15030678"},{"key":"ref_478","doi-asserted-by":"crossref","unstructured":"Du, M., Liu, X., Ji, X., Wang, Y., Liu, X., Zhao, C., Jin, E., Gu, Y., Wang, H., and Zhang, F. (2025). Berberine alleviates enterotoxigenic Escherichia coli-induced intestinal mucosal barrier function damage in a piglet model by modulation of the intestinal microbiome. Front. Nutr., 11.","DOI":"10.3389\/fnut.2024.1494348"},{"key":"ref_479","doi-asserted-by":"crossref","unstructured":"Ozorowski, M., Wici\u0144ski, M., Ku\u017ami\u0144ski, O., Wojciechowski, P., Siedlecki, Z., \u015aniegocki, M., and W\u0142odarczyk, E. (2025). The Effects of Quercetin on Vascular Endothelium, Inflammation, Cardiovascular Disease and Lipid Metabolism\u2014A Review. Nutrients, 17.","DOI":"10.3390\/nu17091579"},{"key":"ref_480","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s13237-024-00491-5","article-title":"Epigallocatechin gallate induces an up-regulation of LDLR accompanied by a reduction of idol in Hepg2 cells","volume":"68","author":"Li","year":"2025","journal-title":"Nuclleus"},{"key":"ref_481","doi-asserted-by":"crossref","unstructured":"Wang, Z.-y., Deng, Y.-l., Zhou, T.-y., Liu, Y., and Cao, Y. (2025). Effects of natural extracts in cognitive function of healthy adults: A systematic review and network meta-analysis. Front. Pharmacol., 16.","DOI":"10.3389\/fphar.2025.1573034"},{"key":"ref_482","unstructured":"Dolan, E.W. (2025, June 09). Study Identifies Top-Performing Natural Extracts for Improving Cognitive Function. Available online: https:\/\/www.psypost.org\/study-identifies-top-performing-natural-extracts-for-improving-cognitive-function\/."},{"key":"ref_483","unstructured":"The Good Trade (2025, October 06). 10 Natural Supplements For Better Brain Health. Available online: https:\/\/www.thegoodtrade.com\/features\/brain-focus-supplements\/."},{"key":"ref_484","doi-asserted-by":"crossref","unstructured":"Lee, J., Kwon, S., Jin, C., Cho, S.-Y., Park, S.-U., Jung, W.-S., Moon, S.-K., Park, J.-M., Ko, C.-N., and Cho, K.-H. (2022). Traditional east asian herbal medicine treatment for Alzheimer\u2019s Disease: A systematic review and meta-analysis. Pharmaceuticals, 15.","DOI":"10.3390\/ph15020174"},{"key":"ref_485","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1002\/ptr.5679","article-title":"Chinese herbal medicine for mild cognitive impairment: A systematic review and meta-analysis of cognitive outcomes","volume":"30","author":"Dong","year":"2016","journal-title":"Phytother. Res."},{"key":"ref_486","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s11655-019-3066-y","article-title":"Sequential therapy based on evolvement of patterns: A new model for treatment of Alzheimer\u2019s disease","volume":"25","author":"Tian","year":"2019","journal-title":"Chin. J. Integr. Med."},{"key":"ref_487","doi-asserted-by":"crossref","first-page":"7117704","DOI":"10.1155\/2022\/7117704","article-title":"Study on the correlation between Chinese medicine syndrome and cognitive dysfunction in mild cognitive impairment","volume":"2022","author":"Lin","year":"2022","journal-title":"Evid.-Based Complement. Altern. Med."},{"key":"ref_488","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.nbd.2011.05.023","article-title":"Gene expression profiling of peripheral blood leukocytes identifies and validates ABCB1 as a novel biomarker for Alzheimer\u2019s disease","volume":"43","author":"Chen","year":"2011","journal-title":"Neurobiol. Dis."},{"key":"ref_489","first-page":"219","article-title":"Initial study on disposition of chinese medical symptoms and signs of mild cognitive impairment for Elder People","volume":"2","author":"Yang","year":"2007","journal-title":"World J. Integr. Tradit. West. Med."},{"key":"ref_490","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jep.2017.07.036","article-title":"Xuefu Zhuyu decoction ameliorates obesity, hepatic steatosis, neuroinflammation, amyloid deposition and cognition impairment in metabolically stressed APPswe\/PS1dE9 mice","volume":"209","author":"Yeh","year":"2017","journal-title":"J. Ethnopharmacol."},{"key":"ref_491","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3233\/JAD-140606","article-title":"Blood genome-wide transcriptional profiles reflect broad molecular impairments and strong blood-brain links in Alzheimer\u2019s disease","volume":"43","author":"Naughton","year":"2014","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_492","doi-asserted-by":"crossref","first-page":"373","DOI":"10.3233\/JAD-121963","article-title":"Characteristic transformation of blood transcriptome in Alzheimer\u2019s disease","volume":"35","author":"Han","year":"2013","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_493","doi-asserted-by":"crossref","unstructured":"Bottero, V., and Potashkin, J.A. (2019). Meta-analysis of gene expression changes in the blood of patients with mild cognitive impairment and Alzheimer\u2019s disease dementia. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20215403"},{"key":"ref_494","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.3233\/JAD-170205","article-title":"Changes in expression profiles revealed by transcriptomic analysis in peripheral blood mononuclear cells of Alzheimer\u2019s disease patients","volume":"66","author":"Leandro","year":"2018","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_495","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.neurobiolaging.2019.07.004","article-title":"Supervised pathway analysis of blood gene expression profiles in Alzheimer\u2019s disease","volume":"84","author":"Moradi","year":"2019","journal-title":"Neurobiol. Aging"},{"key":"ref_496","doi-asserted-by":"crossref","first-page":"104175","DOI":"10.1016\/j.ebiom.2022.104175","article-title":"Impaired type I interferon signaling activity implicated in the peripheral blood transcriptome of preclinical Alzheimer\u2019s disease","volume":"82","author":"Song","year":"2022","journal-title":"eBioMedicine"},{"key":"ref_497","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.neurobiolaging.2013.08.002","article-title":"Alzheimer\u2019s disease susceptibility variants in the MS4A6A gene are associated with altered levels of MS4A6A expression in blood","volume":"35","author":"Proitsi","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"ref_498","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s13195-020-00654-x","article-title":"Identification of potential blood biomarkers for early diagnosis of Alzheimer\u2019s disease through RNA sequencing analysis","volume":"12","author":"Shigemizu","year":"2020","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"ref_499","doi-asserted-by":"crossref","first-page":"611","DOI":"10.3233\/JAD-122404","article-title":"Prediction of mild cognitive impairment that evolves into Alzheimer\u2019s disease dementia within two years using a gene expression signature in blood: A pilot study","volume":"35","author":"Roed","year":"2013","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_500","doi-asserted-by":"crossref","first-page":"737","DOI":"10.3233\/JAD-2012-121363","article-title":"A blood gene expression marker of early Alzheimer\u2019s disease","volume":"33","author":"Lunnon","year":"2013","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_501","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S1474-4422(11)70158-2","article-title":"Functional network disruption in the degenerative dementias","volume":"10","author":"Pievani","year":"2011","journal-title":"Lancet Neurol."},{"key":"ref_502","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.pscychresns.2013.10.010","article-title":"Whole cortical and default mode network mean functional connectivity as potential biomarkers for mild Alzheimer\u2019s disease","volume":"221","author":"Balthazar","year":"2014","journal-title":"Psychiatry Res. Neuroimaging"},{"key":"ref_503","doi-asserted-by":"crossref","first-page":"28982","DOI":"10.1038\/srep28982","article-title":"A two-year treatment of amnestic mild cognitive impairment using a compound Chinese medicine: A placebo controlled randomized trial","volume":"6","author":"Zhang","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_504","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0013-4694(94)90034-5","article-title":"Quantitative topographical EEG compared to FDG PET for classification of vascular and degenerative dementia","volume":"91","author":"Szelies","year":"1994","journal-title":"Electroencephalogr. Clin. Neurophysiol."},{"key":"ref_505","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.neurobiolaging.2017.11.005","article-title":"Quantitative EEG power and synchronization correlate with Alzheimer\u2019s disease CSF biomarkers","volume":"63","author":"Smailovic","year":"2018","journal-title":"Neurobiol. Aging"},{"key":"ref_506","doi-asserted-by":"crossref","first-page":"245091","DOI":"10.1155\/2012\/245091","article-title":"Effect of Toki-Shakuyaku-San on Regional Cerebral Blood Flow in Patients with Mild Cognitive Impairment and Alzheimer\u2032 s Disease","volume":"2012","author":"Matsuoka","year":"2012","journal-title":"Evid.-Based Complement. Altern. Med."},{"key":"ref_507","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s00213-003-1593-9","article-title":"Event-related brain potential changes after Choto-san administration in stroke patients with mild cognitive impairments","volume":"171","author":"Yamaguchi","year":"2004","journal-title":"Psychopharmacology"},{"key":"ref_508","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/00002093-199809000-00019","article-title":"Effectiveness of traditional Chinese medicine in Alzheimer disease","volume":"12","author":"Oishi","year":"1998","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"ref_509","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1089\/acm.2015.0265","article-title":"Effect of Korean red ginseng on cognitive function and quantitative EEG in patients with Alzheimer\u2019s disease: A preliminary study","volume":"22","author":"Heo","year":"2016","journal-title":"J. Altern. Complement. Med."},{"key":"ref_510","doi-asserted-by":"crossref","first-page":"484","DOI":"10.2174\/1567205011666140505095939","article-title":"The effects of CCRC on cognition and brain activity in aMCI patients: A pilot placebo controlled BOLD fMRI study","volume":"11","author":"Zhang","year":"2014","journal-title":"Curr. Alzheimer Res."},{"key":"ref_511","doi-asserted-by":"crossref","first-page":"e71023","DOI":"10.1002\/alz.71023","article-title":"The microbiota\u2013gut\u2013brain axis in mild cognitive impairment and Alzheimer\u2019s disease: A scoping review of human studies","volume":"22","author":"Warren","year":"2026","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_512","doi-asserted-by":"crossref","unstructured":"Wu, W., Meng, T., Han, L., Jin, F., Han, P., and Zhou, Y. (2025). Bridging traditional Chinese medicine and Alzheimer\u2019s disease: The pivotal role of gut microbiota in multitarget therapeutic mechanisms. Front. Pharmacol., 16.","DOI":"10.3389\/fphar.2025.1630205"},{"key":"ref_513","doi-asserted-by":"crossref","unstructured":"Rajini, P., and Muralidhara, M. (2023). Therapeutic efficacy of ayurvedic polyherbal formulations (PHF): Interactive mechanisms and broad-spectrum activities against neurological disorders. Ayurvedic Herbal Preparations in Neurological Disorders, Elsevier.","DOI":"10.1016\/B978-0-443-19084-1.00024-7"},{"key":"ref_514","doi-asserted-by":"crossref","unstructured":"Bhajan, S.K., Bishwas, A.K., Dutta, B., Bala, A., Aktary, N., Park, S., Rahman, M., Choi, M., Choi, J., and Akter, S. (2026). Recent Advancements in Bioactive Natural Products and Nanoparticle-Mediated Drug Delivery in Cancer Therapy. Int. J. Mol. Sci., 27.","DOI":"10.3390\/ijms27031356"},{"key":"ref_515","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.2174\/1570180820666230308105723","article-title":"Application of nanotechnology for herbal medicine development: A review","volume":"21","author":"Anand","year":"2024","journal-title":"Lett. Drug Des. Discov."},{"key":"ref_516","doi-asserted-by":"crossref","first-page":"100773","DOI":"10.1016\/j.rsurfi.2026.100773","article-title":"Nanotechnology in Lung Cancer: Enhancing Targeted Drug Delivery and Diagnostic Precision","volume":"23","author":"Halim","year":"2026","journal-title":"Results Surf. Interfaces"},{"key":"ref_517","doi-asserted-by":"crossref","first-page":"21","DOI":"10.22271\/flora.2016.v4.i3.05","article-title":"Nano-technology in herbal medicines: A review","volume":"4","author":"Chakraborty","year":"2016","journal-title":"Int. J. Herb. Med."},{"key":"ref_518","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1039\/D1PY00176K","article-title":"A multi-responsive self-healing hydrogel for controlled release of curcumin","volume":"12","author":"Pan","year":"2021","journal-title":"Polym. Chem."},{"key":"ref_519","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1208\/s12249-023-02616-6","article-title":"Therapeutic potential of nanocarrier-mediated delivery of phytoconstituents for wound healing: Their current status and future perspective","volume":"24","author":"Kumar","year":"2023","journal-title":"Aaps Pharmscitech"},{"key":"ref_520","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1089\/ten.teb.2024.0002","article-title":"The combination of bioactive herbal compounds with biomaterials for regenerative medicine","volume":"30","author":"Zhou","year":"2024","journal-title":"Tissue Eng. Part B Rev."},{"key":"ref_521","doi-asserted-by":"crossref","first-page":"5449","DOI":"10.1111\/1541-4337.12851","article-title":"Advances in smart delivery of food bioactive compounds using stimuli-responsive carriers: Responsive mechanism, contemporary challenges, and prospects","volume":"20","author":"Shishir","year":"2021","journal-title":"Compr. Rev. Food Sci. Food Saf."},{"key":"ref_522","doi-asserted-by":"crossref","unstructured":"Patel, P., Garala, K., Singh, S., Prajapati, B.G., and Chittasupho, C. (2024). Lipid-based nanoparticles in delivering bioactive compounds for improving therapeutic efficacy. Pharmaceuticals, 17.","DOI":"10.3390\/ph17030329"},{"key":"ref_523","doi-asserted-by":"crossref","first-page":"298","DOI":"10.34172\/PS.2023.6","article-title":"Recent trends in phytosome nanocarriers for improved bioavailability and uptake of herbal drugs","volume":"29","author":"Priya","year":"2023","journal-title":"Pharm. Sci."},{"key":"ref_524","doi-asserted-by":"crossref","first-page":"212","DOI":"10.18231\/j.ijpca.2024.031","article-title":"WHO guidelines for quality control of herbal medicines: From cultivation to consumption","volume":"11","author":"Jain","year":"2024","journal-title":"Int. J. Pharm. Chem. Anal."},{"key":"ref_525","doi-asserted-by":"crossref","first-page":"22","DOI":"10.61882\/pbp.7.4.12","article-title":"Standardization of Medicinal Plants: Ensuring Quality, Safety, and Global Regulatory Compliance in Herbal Drug Development","volume":"7","author":"Dawoud","year":"2025","journal-title":"Plant Biotechnol. Persa"},{"key":"ref_526","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s40264-021-01133-4","article-title":"A review on application of DNA barcoding technology for rapid molecular diagnostics of adulterants in herbal medicine","volume":"45","author":"Senapati","year":"2022","journal-title":"Drug Saf."},{"key":"ref_527","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1080\/03602532.2025.2603936","article-title":"Role of herbal extracts in modulating drug metabolism: Implications for pharmacokinetics, enzyme regulation, and therapeutic outcome","volume":"58","author":"Khan","year":"2026","journal-title":"Drug Metab. Rev."},{"key":"ref_528","doi-asserted-by":"crossref","unstructured":"Soni, S., Rathee, S., Tekade, M., Bharti, A., Gupta, R., and Tekade, R.K. (2026). Translational Case Studies on Marketed Phytomedicines: From Traditional Knowledge to Global Therapeutics. Biomolecular and Safety Considerations of Phytopharmaceuticals, CRC Press.","DOI":"10.1201\/9781003546634-19"},{"key":"ref_529","doi-asserted-by":"crossref","unstructured":"Badria, F.A., and Elgazar, A.A. (2026). The Burden of Inappropriate Polypharmacy: Approaches to Improve Medication Safety. Polypharmacy and Inappropriate Medication Use, IntechOpen.","DOI":"10.5772\/intechopen.1015679"},{"key":"ref_530","first-page":"1","article-title":"Potential Herb-Drug Interaction and Their Clinical Implications: Pharmacokoinetics and Pharmacodynamic Considerations","volume":"8","author":"Kumar","year":"2026","journal-title":"Int. J. Multidiscip. Res."},{"key":"ref_531","doi-asserted-by":"crossref","unstructured":"Mai, N.T.Q., Hieu, N.V., Ngan, T.T., Van Anh, T., Van Linh, P., and Thu Phuong, N.T. (2025). Impact of Ginkgo biloba drug interactions on bleeding risk and coagulation profiles: A comprehensive analysis. PLoS ONE, 20.","DOI":"10.1371\/journal.pone.0321804"},{"key":"ref_532","doi-asserted-by":"crossref","unstructured":"Sefidmooye Azar, P., Akhlaghi, S., Shariat-Madar, Z., and Mahdi, F. (2026). Cognitive-Enhancing Effects of Bioactive Compounds and Traditional Herbal Medicines in Elderly Patients with Metabolic Syndrome. Biomolecules, 16.","DOI":"10.3390\/biom16040535"},{"key":"ref_533","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s002130100815","article-title":"The chronic effects of an extract of Bacopa monniera (Brahmi) on cognitive function in healthy human subjects","volume":"156","author":"Stough","year":"2001","journal-title":"Psychopharmacology"},{"key":"ref_534","first-page":"CD013661","article-title":"Ginkgo biloba for cognitive impairment and dementia","volume":"2","author":"Birks","year":"2009","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_535","doi-asserted-by":"crossref","first-page":"e16071","DOI":"10.1111\/liv.16071","article-title":"Challenges in herbal-induced liver injury identification and prevention","volume":"45","author":"Navarro","year":"2025","journal-title":"Liver Int."},{"key":"ref_536","doi-asserted-by":"crossref","first-page":"100510","DOI":"10.1016\/j.jaim.2021.08.003","article-title":"Efficacy of Withania somnifera supplementation on adult\u2019s cognition and mood","volume":"13","author":"Remenapp","year":"2022","journal-title":"J. Ayurveda Integr. Med."},{"key":"ref_537","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s41465-026-00355-7","article-title":"Effects of Panax ginseng and Panax quinquefolius on Cognitive Function: A Systematic Review","volume":"10","author":"Scholey","year":"2026","journal-title":"J. Cogn. Enhanc."},{"key":"ref_538","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1097\/WAD.0b013e31816c92e6","article-title":"Panax ginseng enhances cognitive performance in Alzheimer disease","volume":"22","author":"Lee","year":"2008","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"ref_539","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s43450-026-00747-y","article-title":"Charting the Phytopharmacological Frontier of Centella asiatica: A Quarter-Century Bibliometric Atlas Unlocking Translational Potential","volume":"36","author":"Yang","year":"2026","journal-title":"Rev. Bras. De Farmacogn."},{"key":"ref_540","doi-asserted-by":"crossref","first-page":"100248","DOI":"10.1016\/j.tjpad.2025.100248","article-title":"Targeting cognitive aging with curcumin supplementation: A systematic review and meta-analysis","volume":"12","author":"Yu","year":"2025","journal-title":"J. Prev. Alzheimer\u2019s Dis."},{"key":"ref_541","doi-asserted-by":"crossref","first-page":"1","DOI":"10.61919\/9ta89295","article-title":"Multi-Target Hepatoprotective Mechanisms of Glycyrrhiza glabra: Molecular Pathways, Experimental Evidence, and Clinical Translation","volume":"4","author":"Rashid","year":"2026","journal-title":"J. Health Wellness Community Res."},{"key":"ref_542","doi-asserted-by":"crossref","unstructured":"Hatayama, K., Kono, K., Okuma, K., and Masuyama, H. (2025). Effect of a specific food intervention with Tamogitake mushroom, Moringa leaves, or rice bran on intestinal microbiota and cognitive function in elderly Japanese. Front. Nutr., 12.","DOI":"10.3389\/fnut.2025.1585111"},{"key":"ref_543","doi-asserted-by":"crossref","unstructured":"Gonz\u00e1lez-S\u00e1nchez, M., Ram\u00edrez-Exp\u00f3sito, M.J., and Mart\u00ednez-Martos, J.M. (2025). Pathophysiology, clinical heterogeneity, and therapeutic advances in amyotrophic lateral sclerosis: A comprehensive review of molecular mechanisms, diagnostic challenges, and multidisciplinary management strategies. Life, 15.","DOI":"10.3390\/life15040647"},{"key":"ref_544","doi-asserted-by":"crossref","unstructured":"Dong, J.M., and Zhong, H. (2025). Systematic Review: Proteomics-Driven Multi-Omics Integration for Alzheimer\u2019s Disease Pathology and Precision Medicine. Neurol. Int., 17.","DOI":"10.3390\/neurolint17120197"},{"key":"ref_545","doi-asserted-by":"crossref","unstructured":"Sheng, C., Du, W., Liang, Y., Xu, P., Ding, Q., Chen, X., Jia, S., and Wang, X. (2023). An integrated neuroimaging-omics approach for the gut-brain communication pathways in Alzheimer\u2019s disease. Front. Aging Neurosci., 15.","DOI":"10.3389\/fnagi.2023.1211979"},{"key":"ref_546","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/s41392-024-01743-1","article-title":"Microbiota\u2013gut\u2013brain axis and its therapeutic applications in neurodegenerative diseases","volume":"9","author":"Loh","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_547","doi-asserted-by":"crossref","first-page":"9793","DOI":"10.1007\/s00371-025-04000-w","article-title":"Decoding the gut\u2013brain axis: Toward AI-driven integration of neuroimaging and gut microbiota in human health","volume":"41","author":"Wu","year":"2025","journal-title":"Vis. Comput."},{"key":"ref_548","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1556\/030.2025.02725","article-title":"Artificial intelligence in gut microbiome research: Toward predictive diagnostics for neurodegenerative disorders","volume":"72","author":"Kumar","year":"2025","journal-title":"Acta Microbiol. Immunol. Hung."},{"key":"ref_549","doi-asserted-by":"crossref","first-page":"32","DOI":"10.9734\/indj\/2026\/v23i1536","article-title":"AI-Driven Detection of Inherited Neurological Disorders Using Genomic and Multi-Omics Data","volume":"23","author":"Ness","year":"2026","journal-title":"Int. Neuropsychiatr. Dis. J."},{"key":"ref_550","doi-asserted-by":"crossref","first-page":"35","DOI":"10.14218\/FIM.2023.00086","article-title":"Exploring the Safety, Efficacy, and Bioactivity of Herbal Medicines: Bridging Traditional Wisdom and Modern Science in Healthcare","volume":"3","author":"Balkrishna","year":"2024","journal-title":"Future Integr. Med."},{"key":"ref_551","doi-asserted-by":"crossref","unstructured":"Rudrapal, M., and Chetia, D. (2021). Herbal Drugs: Efficacy, Toxicity, and Safety Issues. Evidence Based Validation of Traditional Medicines, Springer.","DOI":"10.1007\/978-981-15-8127-4_26"},{"key":"ref_552","doi-asserted-by":"crossref","unstructured":"Koonrungsesomboon, N., Sakuludomkan, C., Na Takuathung, M., Klinjan, P., Sawong, S., and Perera, P.K. (2024). Study design of herbal medicine clinical trials: A descriptive analysis of published studies investigating the effects of herbal medicinal products on human participants. BMC Complement. Med. Ther., 24.","DOI":"10.1186\/s12906-024-04697-7"},{"key":"ref_553","first-page":"CD005593","article-title":"Cholinesterase inhibitors for Alzheimer\u2019s disease","volume":"2006","author":"Birks","year":"2006","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_554","doi-asserted-by":"crossref","first-page":"800.e1","DOI":"10.1016\/j.amjmed.2006.02.006","article-title":"Quality of reporting of randomized controlled trials of herbal medicine interventions","volume":"119","author":"Gagnier","year":"2006","journal-title":"Am. J. Med."},{"key":"ref_555","doi-asserted-by":"crossref","first-page":"443","DOI":"10.2174\/1389200218666171031123738","article-title":"Herb-drug interactions in neurological disorders: A critical appraisal","volume":"19","author":"Wilson","year":"2018","journal-title":"Curr. Drug Metab."},{"key":"ref_556","doi-asserted-by":"crossref","unstructured":"Bhattacharya, T., Soares, G.A.B.E., Chopra, H., Rahman, M.M., Hasan, Z., Swain, S.S., and Cavalu, S. (2022). Applications of phyto-nanotechnology for the treatment of neurodegenerative disorders. Materials, 15.","DOI":"10.3390\/ma15030804"},{"key":"ref_557","doi-asserted-by":"crossref","first-page":"364","DOI":"10.7326\/0003-4819-144-5-200603070-00013","article-title":"Reporting randomized, controlled trials of herbal interventions: An elaborated CONSORT statement","volume":"144","author":"Gagnier","year":"2006","journal-title":"Ann. Intern. Med."},{"key":"ref_558","doi-asserted-by":"crossref","first-page":"5490","DOI":"10.12998\/wjcc.v9.i20.5490","article-title":"Herb-induced liver injury: Systematic review and meta-analysis","volume":"9","author":"Ballotin","year":"2021","journal-title":"World J. Clin. Cases"},{"key":"ref_559","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1089\/ars.2022.0134","article-title":"New insights into herb-induced liver injury","volume":"38","author":"Ma","year":"2023","journal-title":"Antioxid. Redox Signal."},{"key":"ref_560","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1002\/ptr.8384","article-title":"Perspectives, experiences, and practices of healthcare professionals and patients towards herb\u2013drug interaction: A systematic review of qualitative studies","volume":"39","author":"Shen","year":"2025","journal-title":"Phytother. Res."},{"key":"ref_561","doi-asserted-by":"crossref","unstructured":"Puthiyedath, R., and Pillai, Z.S. (2025). Drug\u2013herb interactions: A challenge and clinical concern in primary healthcare. Front. Med., 12.","DOI":"10.3389\/fmed.2025.1657005"},{"key":"ref_562","first-page":"103","article-title":"Evidence-based herbal medicine in efficacy and safety assessments","volume":"8","author":"Park","year":"2008","journal-title":"Adv. Tradit. Med."},{"key":"ref_563","doi-asserted-by":"crossref","first-page":"120","DOI":"10.4254\/wjh.v16.i2.120","article-title":"Insights into skullcap herb-induced liver injury","volume":"16","author":"Soldera","year":"2024","journal-title":"World J. Hepatol."},{"key":"ref_564","doi-asserted-by":"crossref","first-page":"101","DOI":"10.5897\/IJBC11.163","article-title":"Standardization of herbal medicines-A review","volume":"4","author":"Kunle","year":"2012","journal-title":"Int. J. Biodivers. Conserv."},{"key":"ref_565","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/s13643-023-02301-6","article-title":"A systematic review of the safety and efficacy on cognitive function of herbal and nutritional medicines in older adults with and without subjective cognitive impairment","volume":"12","author":"Cave","year":"2023","journal-title":"Syst. Rev."},{"key":"ref_566","doi-asserted-by":"crossref","unstructured":"Moradi, S.Z., Momtaz, S., Bayrami, Z., Farzaei, M.H., and Abdollahi, M. (2020). Nanoformulations of herbal extracts in treatment of neurodegenerative disorders. Front. Bioeng. Biotechnol., 8.","DOI":"10.3389\/fbioe.2020.00238"},{"key":"ref_567","doi-asserted-by":"crossref","unstructured":"Yadav, V., Guin, S., Nayak, S., and Mishra, A. (2024). Herbal Approaches for the Management of Neurological Disorders. Drug Delivery Strategies in Neurological Disorders: Challenges and Opportunities, Springer.","DOI":"10.1007\/978-981-99-6807-7_10"}],"container-title":["Nutrients"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6643\/18\/11\/1796\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T04:58:19Z","timestamp":1780549099000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6643\/18\/11\/1796"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,2]]},"references-count":567,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["nu18111796"],"URL":"https:\/\/doi.org\/10.3390\/nu18111796","relation":{},"ISSN":["2072-6643"],"issn-type":[{"value":"2072-6643","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,2]]}}}